<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName A++V2.4.dtd?>
<?SourceDTD.Version 2.4?>
<?ConverterInfo.XSLTName springer2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">BMC Bioinformatics</journal-id>
    <journal-id journal-id-type="iso-abbrev">BMC Bioinformatics</journal-id>
    <journal-title-group>
      <journal-title>BMC Bioinformatics</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1471-2105</issn>
    <publisher>
      <publisher-name>BioMed Central</publisher-name>
      <publisher-loc>London</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">6889579</article-id>
    <article-id pub-id-type="publisher-id">3216</article-id>
    <article-id pub-id-type="doi">10.1186/s12859-019-3216-4</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Research Article</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>A novel target convergence set based random walk with restart for prediction of potential LncRNA-disease associations</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Li</surname>
          <given-names>Jiechen</given-names>
        </name>
        <address>
          <email>395557205@qq.com</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Li</surname>
          <given-names>Xueyong</given-names>
        </name>
        <address>
          <email>xueyongli@163.com</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Feng</surname>
          <given-names>Xiang</given-names>
        </name>
        <address>
          <email>fengxiang@xtu.edu.cn</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Wang</surname>
          <given-names>Bing</given-names>
        </name>
        <address>
          <email>wangbing@ustc.edu</email>
        </address>
        <xref ref-type="aff" rid="Aff3">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zhao</surname>
          <given-names>Bihai</given-names>
        </name>
        <address>
          <email>bihaizhao@163.com</email>
        </address>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5065-8447</contrib-id>
        <name>
          <surname>Wang</surname>
          <given-names>Lei</given-names>
        </name>
        <address>
          <email>wanglei@xtu.edu.cn</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.448798.e</institution-id><institution>College of Computer Engineering &amp; Applied Mathematics, </institution><institution>Changsha University, </institution></institution-wrap>Changsha, Hunan People’s Republic of China </aff>
      <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 8633 7608</institution-id><institution-id institution-id-type="GRID">grid.412982.4</institution-id><institution>Key Laboratory of Hunan Province for Internet of Things and Information Security, </institution><institution>Xiangtan University, </institution></institution-wrap>XiangTan, People’s Republic of China </aff>
      <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1790 1075</institution-id><institution-id institution-id-type="GRID">grid.440650.3</institution-id><institution>School of Electrical and Information Engineering, </institution><institution>Anhui University of Technology, </institution></institution-wrap>Anhui 243002 Maanshan, People’s Republic of China </aff>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>3</day>
      <month>12</month>
      <year>2019</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>3</day>
      <month>12</month>
      <year>2019</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2019</year>
    </pub-date>
    <volume>20</volume>
    <elocation-id>626</elocation-id>
    <history>
      <date date-type="received">
        <day>8</day>
        <month>2</month>
        <year>2019</year>
      </date>
      <date date-type="accepted">
        <day>12</day>
        <month>11</month>
        <year>2019</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s). 2019</copyright-statement>
      <license license-type="OpenAccess">
        <license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
      </license>
    </permissions>
    <abstract id="Abs1">
      <sec>
        <title>Background</title>
        <p id="Par1">In recent years, lncRNAs (long-non-coding RNAs) have been proved to be closely related to the occurrence and development of many serious diseases that are seriously harmful to human health. However, most of the lncRNA-disease associations have not been found yet due to high costs and time complexity of traditional bio-experiments. Hence, it is quite urgent and necessary to establish efficient and reasonable computational models to predict potential associations between lncRNAs and diseases.</p>
      </sec>
      <sec>
        <title>Results</title>
        <p id="Par2">In this manuscript, a novel prediction model called TCSRWRLD is proposed to predict potential lncRNA-disease associations based on improved random walk with restart. In TCSRWRLD, a heterogeneous lncRNA-disease network is constructed first by combining the integrated similarity of lncRNAs and the integrated similarity of diseases. And then, for each lncRNA/disease node in the newly constructed heterogeneous lncRNA-disease network, it will establish a node set called TCS (Target Convergence Set) consisting of top 100 disease/lncRNA nodes with minimum average network distances to these disease/lncRNA nodes having known associations with itself. Finally, an improved random walk with restart is implemented on the heterogeneous lncRNA-disease network to infer potential lncRNA-disease associations. The major contribution of this manuscript lies in the introduction of the concept of TCS, based on which, the velocity of convergence of TCSRWRLD can be quicken effectively, since the walker can stop its random walk while the walking probability vectors obtained by it at the nodes in TCS instead of all nodes in the whole network have reached stable state. And Simulation results show that TCSRWRLD can achieve a reliable AUC of 0.8712 in the Leave-One-Out Cross Validation (LOOCV), which outperforms previous state-of-the-art results apparently. Moreover, case studies of lung cancer and leukemia demonstrate the satisfactory prediction performance of TCSRWRLD as well.</p>
      </sec>
      <sec>
        <title>Conclusions</title>
        <p id="Par3">Both comparative results and case studies have demonstrated that TCSRWRLD can achieve excellent performances in prediction of potential lncRNA-disease associations, which imply as well that TCSRWRLD may be a good addition to the research of bioinformatics in the future.</p>
      </sec>
    </abstract>
    <kwd-group xml:lang="en">
      <title>Keywords</title>
      <kwd>Potential lncRNA-disease association prediction</kwd>
      <kwd>Heterogeneous network</kwd>
      <kwd>Random walk with restart</kwd>
      <kwd>Target convergence set</kwd>
      <kwd>Global set</kwd>
    </kwd-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id>
            <institution>National Natural Science Foundation of China</institution>
          </institution-wrap>
        </funding-source>
        <award-id>61873221</award-id>
        <award-id>61672447</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004735</institution-id>
            <institution>Natural Science Foundation of Hunan Province</institution>
          </institution-wrap>
        </funding-source>
        <award-id>2018JJ4058</award-id>
        <award-id>2017JJ5036</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>CERNET Next Generation Internet Technology Innovation Project</institution>
        </funding-source>
        <award-id>NGII20160305</award-id>
        <award-id>NGII20170109</award-id>
      </award-group>
    </funding-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>issue-copyright-statement</meta-name>
        <meta-value>© The Author(s) 2019</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="Sec1">
    <title>Background</title>
    <p id="Par22">For many years, the genetic information of organism is considered to be stored only in genes used for protein coding, and RNAs have always been thought to be an intermediary in the process of encoding proteins by DNAs [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. However, recent studies have shown that the genes used to encode proteins only account for a small part (less than 2%) of human genome and more than 98% of human genome are not made up of genes that encode proteins and yield a big mount of ncRNAs (non-coding-RNAs) [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]. In addition, as the complexity of biological organisms increases, so does the importance of ncRNAs in biological processes [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]. Generally, ncRNAs can be divided into two major categories such as small ncRNAs and long ncRNAs (lncRNAs) according to the length of nucleotides during transcription, where small ncRNAs consist of less than 200 nucleotides and include microRNAs and transfer RNAs etc. However, lncRNAs consist of more than 200 nucleotides [<xref ref-type="bibr" rid="CR7">7</xref>–<xref ref-type="bibr" rid="CR9">9</xref>]. In 1990, the first two kinds of lncRNAs such as H19 and Xist were discovered by researchers through gene mapping. Since gene mapping approach is extremely time-consuming and labor-intensive, then researches in the field of lncRNAs have been at a relatively slow pace for a long time [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. In recent years, with the rapid development of high-throughput technologies in gene sequencing, more and more lncRNAs have been found in eukaryotes and other species [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. Moreover, simulation results have shown as well that lncRNAs play important roles in various physiological processes such as cell differentiation and death, regulation of epigenetic shape and so on [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. Simultaneously, growing evidences have further illustrated that lncRNAs are closely linked to diseases that pose a serious threat to human health [<xref ref-type="bibr" rid="CR16">16</xref>–<xref ref-type="bibr" rid="CR18">18</xref>], which means that lncRNAs can be used as potential biomarkers in the course of disease treatment in the future [<xref ref-type="bibr" rid="CR19">19</xref>].</p>
    <p id="Par23">With the discovery of a large number of new types of lncRNAs, many databases related to lncRNAs such as lncRNAdisease [<xref ref-type="bibr" rid="CR20">20</xref>], lncRNAdb [<xref ref-type="bibr" rid="CR21">21</xref>], NONCODE [<xref ref-type="bibr" rid="CR22">22</xref>] and Lnc2Cancer [<xref ref-type="bibr" rid="CR23">23</xref>] have been established by researchers successively, however, in these databases, the number of known associations between lncRNAs and diseases is still very limited due to high costs and time-consumption of traditional biological experiments. Thus, it is meaningful to develop mathematical models to predict potential lncRNA-disease associations quickly and massively. Based on the assumption that similar diseases tend to be more likely associated with similar lncRNAs [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>], up to now, a good deal of computational models for inferring potential lncRNA-disease associations have been proposed. For instance, Chen et al. proposed a computational model called LRLSLDA [<xref ref-type="bibr" rid="CR26">26</xref>] for prediction of potential lncRNA-disease associations by adopting the method of Laplacian regularized least squares. Ping and Wang et al. constructed a prediction model for extracting feature information from bipartite interactive networks [<xref ref-type="bibr" rid="CR27">27</xref>]. Zhao and Wang et al. developed a computational model based on Distance Correlation Set to uncover potential lncRNA-disease associations through integrating known associations between three kinds of nodes such as disease nodes, miRNA nodes and lncRNA nodes into a complex network [<xref ref-type="bibr" rid="CR28">28</xref>]. Chen et al. proposed an lncRNA-disease association prediction model based on a heterogeneous network by considering the influence of path length between nodes on the similarity of nodes in the heterogeneous network [<xref ref-type="bibr" rid="CR29">29</xref>–<xref ref-type="bibr" rid="CR31">31</xref>]. However, for some time past, a network traversal method called RWR (Random Walk with Restart) has emerged in the field of computational biology including prediction of potential miRNA-disease associations [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR33">33</xref>], drug-target associations [<xref ref-type="bibr" rid="CR34">34</xref>] and lncRNA-disease associations [<xref ref-type="bibr" rid="CR35">35</xref>–<xref ref-type="bibr" rid="CR37">37</xref>] etc.</p>
    <p id="Par24">Inspired by the thoughts illustrated in above state-of-the-art literatures, in this paper, a computational model called TCSRWRLD is proposed to discover potential lncRNA-disease associations. In TCSRWRLD, a heterogeneous network is constructed first through combining known lncRNA-disease associations with the lncRNA integrated similarity and the disease integrated similarity, which can overcome a drawback of traditional RWR based approaches that these approaches cannot start walking process while there are no known lncRNA-disease associations. And then, each node in the heterogeneous network will establish its own TCS according to the information of network distance, which can reflect the specificity of different nodes in the walking process and make the prediction more accurate and less time-consuming. Moreover, considering that for a given walker, while its TCS has reached the ultimate convergence state, there may be still some nodes that are not included in its TCS but actually associated with it, then in order to ensure that there is no omission in our prediction results, each node in the heterogeneous network will further establish its own GS as well. Finally, for evaluating the prediction performance of our newly proposed model TCSRWRLD, cross validation are implemented based on known lncRNA-disease associations downloaded from the lncRNAdisease database (2017version), and as a result, TCSRWRLD can achieve reliable AUCs of 0.8323, 0.8597, 0.8665 and 0.8712 under the frameworks of 2-folds CV, 5-folds CV, 10-folds CV and LOOCV respectively. In addition, simulation results in case studies of leukemia and lung cancer show that there are 5 and 7 out of the top 10 predicted lncRNAs having been confirmed to be associated with Leukemia and Lung cancer respectively by recent evidences, which demonstrate as well that our model TCSRWRLD has excellent prediction performance.</p>
  </sec>
  <sec id="Sec2">
    <title>Results</title>
    <p id="Par25">In order to verify the performance of TCSRWRLD in predicting potential lncRNA-disease associations, LOOCV, 2-folds CV, 5-folds CV and 10-folds CV were implemented on TCSRWRLD respectively. And then, based on the dataset of 2017-version downloaded from the lncRNADisease database, we obtained the Precision-Recall curve (P-R curve) of TCSRWRLD. In addition, based on the dataset of 2017-version downloaded from the lncRNADisease database and the dataset of 2016-version downloaded from the lnc2Cancer database, we compared TCSRWRLD with state-of-the-art prediction models such as KATZLDA, PMFILDA [<xref ref-type="bibr" rid="CR38">38</xref>] and Ping’s model separately. After that, we further analyzed the influences of key parameters on the prediction performance of TCSRWRLD. Finally, case studies of leukemia and lung cancer were performed to validate the feasibility of TCSRWRLD as well.</p>
    <sec id="Sec3">
      <title>Cross validation</title>
      <p id="Par26">In this section, ROC curve (Receiver Operating Characteristic) and the score of AUC (Area Under ROC Curve) will be adopted to measure the performance of TCSRWRLD in different cross validations. Here, let TPR (True Positive Rates or Sensitivity) represent the percentage of candidate lncRNAs-disease associations with scores higher than a given score cutoff, and FPR (False Positive Rates or 1-Specificity) denote the ratio of predicted lncRNA-disease associations with scores below the given threshold, then ROC curves can be obtained by connecting the corresponding pairs of TPR and FPR on the graph. As illustrated in Fig. <xref rid="Fig1" ref-type="fig">1</xref>, simulation results show that TCSRWRLD can achieve reliable AUCs of 0.8323, 0.8597, 0.8665 and 0.8712 in the frameworks of 2-folds CV, 5-folds CV, 10-folds and LOOCV respectively, which implies that TCSRWRLD can achieve excellent performance in predicting potential lncRNA-disease associations.
<fig id="Fig1"><label>Fig. 1</label><caption><p>AUCs achieved by TCSRWRLD under the frameworks of 2-folds CV, 5-folds CV, 10-folds CV and LOOCV respectively</p></caption><graphic xlink:href="12859_2019_3216_Fig1_HTML" id="MO1"/></fig></p>
      <p id="Par27">Moreover, in order to further estimate the prediction performance of TCSRWRLD, we will obtain the P-R curve of TCSRWRLD as well. Unlike the AUC, the AUPR (Area Under the Precision-Recall curve) represents the ratio of all true positives to all positive predictions at every given recall rate. As illustrated in Fig. <xref rid="Fig2" ref-type="fig">2</xref>, simulation results show that TCSRWRLD can achieve a reliable AUPR of 0.5007.
<fig id="Fig2"><label>Fig. 2</label><caption><p>precision-recall curve achieved by TCSRWRLD</p></caption><graphic xlink:href="12859_2019_3216_Fig2_HTML" id="MO2"/></fig></p>
    </sec>
    <sec id="Sec4">
      <title>Comparison with other related methods</title>
      <p id="Par28">From above descriptions, it is easy to know that TCSRWRLD can achieve satisfactory prediction performance. In this section, we will compare TCSRWRLD with some classical prediction models to further demonstrate the performance of TCSRWRLD. Firstly, based on the dataset of 2017-version downloaded from the lncRNAdisease database, we will compare TCSRWRLD with the state-of-the-art models such as KATZLDA, PMFILDA and Ping’s model. As shown in Fig. <xref rid="Fig3" ref-type="fig">3</xref>, it is easy to see that TCSRWRLD can achieve a reliable AUC of 0.8712 in LOOCV, which is superior to the AUCs of 0.8257, 0.8702 and 0.8346 achieved by KATZLDA, Ping’s model and PMFILDA in LOOCV respectively.
<fig id="Fig3"><label>Fig. 3</label><caption><p>The AUCs achieved by TCSRWRLD, KATZLDA, Ping’s model and PMFILDA in LOOCV based on the dataset of 2017-version downloaded from the lncRNAdisease database</p></caption><graphic xlink:href="12859_2019_3216_Fig3_HTML" id="MO3"/></fig></p>
      <p id="Par29">Moreover, in order to prove that TCSRWRLD can perform well in different data backgrounds, we also adopt the dataset of 2016-version downloaded from the lnc2Cancer database, which consists of 98 human cancers, 668 lncRNAs and 1103 confirmed associations between them, to compare TCSRWRLD with KATZLDA, PMFILDA and Ping’s model. As illustrated in Fig. <xref rid="Fig4" ref-type="fig">4</xref>, it is easy to see that TCSRWRLD can achieve a reliable AUC of 0.8475 in LOOCV, which is superior to the AUCs of 0.8204 and 0.8374 achieved by KATZLDA and PMFILDA respectively, while is inferior to the AUC of 0.8663 achieved by Ping’s model.
<fig id="Fig4"><label>Fig. 4</label><caption><p>the AUCs achieved by TCSRWRLD, KATZLDA, Ping’s model and PMFILDA based on the dataset of 2016-version downloaded from the Lnc2Cancer database</p></caption><graphic xlink:href="12859_2019_3216_Fig4_HTML" id="MO4"/></fig></p>
    </sec>
    <sec id="Sec5">
      <title>Analysis on effects of parameters</title>
      <p id="Par30">In TCSRWRLD, there are some key parameters such as <inline-formula id="IEq1"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {\gamma}_l^{\prime } $$\end{document}</tex-math><mml:math id="M2" display="inline"><mml:mspace width="0.25em"/><mml:msubsup><mml:mi>γ</mml:mi><mml:mi>l</mml:mi><mml:mo>′</mml:mo></mml:msubsup></mml:math><inline-graphic xlink:href="12859_2019_3216_Article_IEq1.gif"/></alternatives></inline-formula>, <inline-formula id="IEq2"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {\gamma}_d^{\prime } $$\end{document}</tex-math><mml:math id="M4" display="inline"><mml:mspace width="0.25em"/><mml:msubsup><mml:mi>γ</mml:mi><mml:mi>d</mml:mi><mml:mo>′</mml:mo></mml:msubsup></mml:math><inline-graphic xlink:href="12859_2019_3216_Article_IEq2.gif"/></alternatives></inline-formula> and <italic>∂</italic>. As for <inline-formula id="IEq3"><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {\gamma}_l^{\prime } $$\end{document}</tex-math><mml:math id="M6" display="inline"><mml:mspace width="0.25em"/><mml:msubsup><mml:mi>γ</mml:mi><mml:mi>l</mml:mi><mml:mo>′</mml:mo></mml:msubsup></mml:math><inline-graphic xlink:href="12859_2019_3216_Article_IEq3.gif"/></alternatives></inline-formula> and <inline-formula id="IEq4"><alternatives><tex-math id="M7">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {\gamma}_d^{\prime } $$\end{document}</tex-math><mml:math id="M8" display="inline"><mml:msubsup><mml:mi>γ</mml:mi><mml:mi>d</mml:mi><mml:mo>′</mml:mo></mml:msubsup><mml:mspace width="0.25em"/></mml:math><inline-graphic xlink:href="12859_2019_3216_Article_IEq4.gif"/></alternatives></inline-formula> in the Equation (<xref rid="Equ5" ref-type="">5</xref>) and Equation (<xref rid="Equ11" ref-type="">11</xref>), we have already known that the model can achieve the best performance when the values of <inline-formula id="IEq5"><alternatives><tex-math id="M9">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {\gamma}_l^{\prime } $$\end{document}</tex-math><mml:math id="M10" display="inline"><mml:msubsup><mml:mi>γ</mml:mi><mml:mi>l</mml:mi><mml:mo>′</mml:mo></mml:msubsup><mml:mspace width="0.25em"/></mml:math><inline-graphic xlink:href="12859_2019_3216_Article_IEq5.gif"/></alternatives></inline-formula>and<inline-formula id="IEq6"><alternatives><tex-math id="M11">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {\gamma}_d^{\prime } $$\end{document}</tex-math><mml:math id="M12" display="inline"><mml:mspace width="0.25em"/><mml:msubsup><mml:mi>γ</mml:mi><mml:mi>d</mml:mi><mml:mo>′</mml:mo></mml:msubsup></mml:math><inline-graphic xlink:href="12859_2019_3216_Article_IEq6.gif"/></alternatives></inline-formula> are both set to 1 [<xref ref-type="bibr" rid="CR39">39</xref>]. Hence, in order to estimate effect of the key parameter <italic>∂</italic> on the prediction performance of TCSRWRLD, we will set the value range of <italic>∂</italic> from 0.1 to 0.9 and select the value of AUC in LOOCV as the basis of parameter selection in this section. As illustrated in Table <xref rid="Tab1" ref-type="table">1</xref>, It is easy to see that TCSRWRLD can achieve the highest value of AUC in LOOCV while <italic>∂</italic> is set to 0.4. Moreover, it is also easy to see that TCSRWRLD can maintain robustness for different values of <italic>∂</italic>, which means that TCSRWRLD is not sensitive to the values of <italic>∂</italic> as well.
<table-wrap id="Tab1"><label>Table 1</label><caption><p>AUCs achieved by TCSRWRLD in LOOCV while the parameter <italic>∂</italic> is set to different values from 0.1 to 0.9</p></caption><table frame="hsides" rules="groups"><thead><tr><th><italic>∂</italic></th><th>0.1</th><th>0.2</th><th>0.3</th><th>0.4</th><th>0.5</th><th>0.6</th><th>0.7</th><th>0.8</th><th>0.9</th></tr></thead><tbody><tr><td>AUC</td><td char="." align="char">0.8418</td><td char="." align="char">0.8655</td><td char="." align="char">0.8707</td><td char="." align="char">0.8712</td><td char="." align="char">0.8700</td><td char="." align="char">0.8680</td><td char="." align="char">0.8700</td><td char="." align="char">0.8672</td><td char="." align="char">0.8660</td></tr></tbody></table></table-wrap></p>
    </sec>
    <sec id="Sec6">
      <title>Case studies</title>
      <p id="Par31">Up to now, cancer is considered as one of the most dangerous diseases to human health because it is hard to be treated [<xref ref-type="bibr" rid="CR40">40</xref>]. At present, the incidence of various cancers has a high level not only in the developing countries where medical development is relatively backward, but also in the developed countries where the medical level is already very high. Hence, in order to further evaluate the performance of TCSRWRLD, case study of two kinds of dangerous cancers such as lung cancer and leukemia will be implemented in this section. As for these two kinds of dangerous cancers, the incidence of lung cancer has remained high in recent years, and the number of lung cancer deaths per year is about 1.8 million, which is the highest of any cancer types. However, the survival rate within five years after the diagnosis of lung cancer is only about 15%, which is much lower than that of other cancers [<xref ref-type="bibr" rid="CR41">41</xref>]. Recently, growing evidences have shown that lncRNAs play crucial roles in the development and occurrence of lung cancer [<xref ref-type="bibr" rid="CR42">42</xref>]. As illustrated in Table <xref rid="Tab2" ref-type="table">2</xref>, while implementing TCSRWRLD to predict lung cancer related lncRNAs, there are 7 out of the top 10 predicted candidate lung cancer related lncRNAs having been confirmed by the latest experimental evidences. Additionally, as a blood-related cancer [<xref ref-type="bibr" rid="CR43">43</xref>], Leukemia has also been found to be closely related to a variety of lncRNAs in recent years. As illustrated in Table <xref rid="Tab2" ref-type="table">2</xref>, while implementing TCSRWRLD to predict Leukemia related lncRNAs, there are 5 out of the top 10 predicted candidate Leukemia related lncRNAs having been confirmed by state-of-the-art experiment results as well. Thus, from above simulation results of case studies, we can easily reach an agreement that TCSRWRLD may have great value in predicting potential lncRNA-disease associations.
<table-wrap id="Tab2"><label>Table 2</label><caption><p>Evidences of top 10 potential leukemia-related lncRNAs and lung cancer-related lncRNAs predicted by TCSRWRLD</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Disease name</th><th>LncRNA name</th><th>RANK</th><th>Evidence</th></tr></thead><tbody><tr><td>Lung cancer</td><td>YUG1</td><td>1</td><td>Lnc2Cancer</td></tr><tr><td>Lung cancer</td><td>XIST</td><td>2</td><td>Lnc2Cancer</td></tr><tr><td>Lung cancer</td><td>PVT1</td><td>4</td><td>Lnc2Cancer</td></tr><tr><td>Lung cancer</td><td>PCAT29</td><td>5</td><td>MNDR</td></tr><tr><td>Lung cancer</td><td>HOTAIRM1</td><td>7</td><td>MNDR</td></tr><tr><td>Lung cancer</td><td>NEAT1</td><td>9</td><td>Lnc2Cancer</td></tr><tr><td>Lung cancer</td><td>anti-NOS2A</td><td>10</td><td>Lnc2Cancer</td></tr><tr><td>Leukemia</td><td>MALAT1</td><td>1</td><td>Lnc2Cancer</td></tr><tr><td>Leukemia</td><td>HOTAIR</td><td>2</td><td>Lnc2Cancer</td></tr><tr><td>Leukemia</td><td>H19</td><td>4</td><td>Lnc2Cancer</td></tr><tr><td>Leukemia</td><td>MEG3</td><td>5</td><td>Lnc2Cancer</td></tr><tr><td>Leukemia</td><td>PVT1</td><td>7</td><td>Lnc2Cancer</td></tr></tbody></table></table-wrap></p>
    </sec>
  </sec>
  <sec id="Sec7">
    <title>Discussion</title>
    <p id="Par32">Since it is very time-consuming and labor-intensive to verify associations between lncRNAs and diseases through traditional biological experiments, then it has become a hot topic in bioinformatics to establish computational models to infer potential lncRNA-disease associations, which can help researchers to have a deeper understanding of diseases at the lncRNA level. In this manuscript, a novel prediction model called TCSRWRLD is proposed, in which, a heterogeneous network is constructed first through combining the disease integrated similarity, the lncRNA integrated similarity and known lncRNA-disease associations, which can guarantee that TCSRWRLD is able to overcome the shortcomings of traditional RWR based prediction models that the random walk process cannot be started while there are no known lncRNA-disease associations. And then, based on the newly constructed heterogeneous network, a random walk based prediction model is further designed based on the concepts of TCS and GS. In addition, based on the dataset of 2017-version downloaded from the lncRNAdisease database, a variety of simulations have been implemented, and simulation results show that TCSRWRLD can achieve reliable AUCs of 0.8323, 0.8597 0.8665 and 0.8712 under the frameworks of 2-fold CV, 5-fold CV, 10-fold CV and LOOCV respectively. Additionally, simulation results of case studies of lung cancer and leukemia show as well that TCSRWRLD has a reliable diagnostic ability in predicting potential lncRNA-disease associations. Certainly, the current version of TCSRWRLD still has some shortages and deficiencies. For example, the prediction performance of TCSRWRLD can be further improved if more known lncRNA-disease associations have been added into the experimental datasets. In addition, more accurate establishment of Mesh database will help us obtain more accurate disease semantic similarity scores, which is very important for the calculation of lncRNA functional similarity as well. Of course, all these above problems will be the focus of our future researches.</p>
  </sec>
  <sec id="Sec8">
    <title>Conclusion</title>
    <p id="Par33">In this paper, the main contributions are as follows: (1) A heterogeneous lncRNA-disease network is constructed by integrating three kinds of networks such as the known lncRNA-disease association network, the disease-disease similarity network and the lncRNA-lncRNA similarity network. (2) Based on the newly constructed heterogeneous lncRNA-disease network, the concept of network distance is introduced to establish the TCS (Target Convergence Set) and GS (Global Set) for each node in the heterogeneous lncRNA-disease network. (3) Based on the concepts of TCS and GS, a novel random walk model is proposed to infer potential lncRNA-disease associations. (4) Through comparison with traditional state-of-the-art prediction models and the simulation results of case studies, TCSRWRLD is demonstrated to be of excellent prediction performance in uncovering potential lncRNA-disease associations.</p>
  </sec>
  <sec id="Sec9">
    <title>Methods and materials</title>
    <sec id="Sec10">
      <title>Known disease-lncRNA associations</title>
      <p id="Par34">Firstly, we download the 2017-version of known lncRNA-disease associations from the lncRNAdisease database (<ext-link ext-link-type="uri" xlink:href="http://www.cuilab.cn/">http://www.cuilab.cn/</ext-link> lncrnadisease). And then, after removing duplicated associations and picking out the lncRNA-disease associations from the raw data, we finally obtain 1695 known lncRNA-disease associations (see Additional file <xref rid="MOESM1" ref-type="media">1</xref>) including 828 different lncRNAs (see Additional file <xref rid="MOESM2" ref-type="media">2</xref>) and 314 different diseases (see Additional file <xref rid="MOESM3" ref-type="media">3</xref>). Hence, we can construct a 314 × 828 dimensional lncRNA-disease association adjacency matrix <italic>A</italic>, in which, there is <italic>A</italic>(<italic>i</italic>, <italic>j</italic>) = 1, if and only if there is an known association between the disease <italic>d</italic><sub><italic>i</italic></sub> and the lncRNA <italic>l</italic><sub><italic>j</italic></sub> in the LncRNADisease database, otherwise there is <italic>A</italic>(<italic>i</italic>, <italic>j</italic>) = 0. In addition, for convenience of description, let <italic>N</italic><sub><italic>L</italic></sub> = 828 and <italic>N</italic><sub><italic>D</italic></sub> = 314, then it is obvious that the dimension of the lncRNA-disease association adjacency matrix <italic>A</italic> can be represented as <italic>N</italic><sub><italic>D</italic></sub> × <italic>N</italic><sub><italic>L</italic></sub>. And the like mentioned above, we can get a cancer-disease associations adjacency matrix which dimension is 98 × 668 (It comes from 2016-version of known lncRNA-disease associations from the Lnc2Cancer database) (see Additional file <xref rid="MOESM4" ref-type="media">4</xref>).</p>
    </sec>
    <sec id="Sec11">
      <title>Similarity of diseases</title>
      <sec id="Sec12">
        <title>Semantic similarity of diseases</title>
        <p id="Par35">In order to estimate the semantic similarity between different diseases, based on the concept of DAGs (Directed Acyclic Graph) of different diseases proposed by Wang et al. [<xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR45">45</xref>], we can calculate the disease semantic similarity through calculating the similarity between compositions of DAGs of different diseases as follows:</p>
        <sec id="FPar1">
          <title>Step 1</title>
          <p id="Par36">For all these 314 diseases newly obtained from the lncRNAdisease database, their corresponding MESH descriptors can be downloaded from the Mesh database in the National Library of Medicine (<ext-link ext-link-type="uri" xlink:href="http://www.nlm.nih.gov/">http://www.nlm.nih.gov/</ext-link>). As illustrated in Fig. <xref rid="Fig5" ref-type="fig">5</xref>, based on the information of MESH descriptors, each disease can establish a DAG of its own.
<fig id="Fig5"><label>Fig. 5</label><caption><p>DAG of the digestive system neoplasms and breast neoplasms</p></caption><graphic xlink:href="12859_2019_3216_Fig5_HTML" id="MO5"/></fig></p>
        </sec>
        <sec id="FPar2">
          <title>Step 2</title>
          <p id="Par37">For any given disease <italic>d</italic>, Let its DAG be DAG(<italic>d</italic>) = (<italic>d</italic>, <italic>D</italic>(<italic>d</italic>), <italic>E</italic>(<italic>d</italic>)), where <italic>D</italic>(<italic>d</italic>) represents a set of nodes consisting of the disease <italic>d</italic> itself and its ancestral disease nodes, and <italic>E</italic>(<italic>d</italic>) denotes a set of directed edges pointing from ancestral nodes to descendant nodes.</p>
        </sec>
        <sec id="FPar3">
          <title>Step 3</title>
          <p id="Par38">For any given disease <italic>d</italic> and one of its ancestor nodes <italic>t</italic> in DAG(<italic>d</italic>), the semantic contributions of the ancestor node <italic>t</italic> to the disease <italic>d</italic> can be defined as follows:
<disp-formula id="Equ1"><label>1</label><alternatives><tex-math id="M13">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {D}_d(t)=\left\{\begin{array}{c}1\\ {}\max \left\{\varDelta \ast {D}_d\left(t\hbox{'}\right)|t\hbox{'}\in children\kern0.17em of\;t\right\}\kern1em \begin{array}{c} if\;t=d\\ {} if\;t\ne d\end{array}\end{array}\right\} $$\end{document}</tex-math><mml:math id="M14" display="block"><mml:msub><mml:mi>D</mml:mi><mml:mi>d</mml:mi></mml:msub><mml:mfenced close=")" open="("><mml:mi>t</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mfenced close="}" open="{" separators=","><mml:mtable><mml:mtr><mml:mtd><mml:mn>1</mml:mn></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mo>max</mml:mo><mml:mfenced close="}" open="{" separators="|"><mml:mrow><mml:mi>Δ</mml:mi><mml:mo>∗</mml:mo><mml:msub><mml:mi>D</mml:mi><mml:mi>d</mml:mi></mml:msub><mml:mfenced close=")" open="("><mml:mrow><mml:mi>t</mml:mi><mml:mo>'</mml:mo></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mo>'</mml:mo><mml:mo>∈</mml:mo><mml:mtext mathvariant="italic">children of</mml:mtext><mml:mspace width="0.12em"/><mml:mi>t</mml:mi></mml:mrow></mml:mfenced><mml:mspace width="1em"/><mml:mtable><mml:mtr><mml:mtd><mml:mtext mathvariant="italic">if</mml:mtext><mml:mspace width="0.12em"/><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mi>d</mml:mi></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mtext mathvariant="italic">if</mml:mtext><mml:mspace width="0.12em"/><mml:mi>t</mml:mi><mml:mo>≠</mml:mo><mml:mi>d</mml:mi></mml:mtd></mml:mtr></mml:mtable></mml:mtd></mml:mtr></mml:mtable></mml:mfenced></mml:math><graphic xlink:href="12859_2019_3216_Article_Equ1.gif" position="anchor"/></alternatives></disp-formula></p>
          <p id="Par39">Where Δ is the attenuation factor with value between 0 and 1 to calculate the disease semantic contribution, and according to the state-of-the-art experimental results, the most appropriate value for<italic>Δ</italic>is 0.5 .</p>
        </sec>
        <sec id="FPar4">
          <title>Step 4</title>
          <p id="Par40">For any given disease <italic>d</italic>, let its DAG be DAG(<italic>d</italic>), then based on the concept of DAG, the semantic value of <italic>d</italic> can be defined as follows:
<disp-formula id="Equ2"><label>2</label><alternatives><tex-math id="M15">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ D(d)={\sum \limits}_{t_i\in DAG(d)}{D}_d\left({t}_i\right) $$\end{document}</tex-math><mml:math id="M16" display="block"><mml:mi>D</mml:mi><mml:mfenced close=")" open="("><mml:mi>d</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:msub><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:msub><mml:mi>t</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>∈</mml:mo><mml:mi mathvariant="italic">DAG</mml:mi><mml:mfenced close=")" open="("><mml:mi>d</mml:mi></mml:mfenced></mml:mrow></mml:msub><mml:msub><mml:mi>D</mml:mi><mml:mi>d</mml:mi></mml:msub><mml:mfenced close=")" open="("><mml:msub><mml:mi>t</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mfenced></mml:math><graphic xlink:href="12859_2019_3216_Article_Equ2.gif" position="anchor"/></alternatives></disp-formula></p>
          <p id="Par41">Taking the disease DSN (Digestive Systems Neoplasms) illustrated in Fig. <xref rid="Fig5" ref-type="fig">5</xref> for example, according to the Equation (<xref rid="Equ1" ref-type="">1</xref>), it is easy to know that the semantic contribution of digestive systems neoplasms to itself is 1. Besides, since the neoplasms by site and the digestive system disease located in the second layer of the DAG of DSN, then it is obvious that both of the semantic contributions of these two kinds of diseases to DSN are 0.5*1 = 0.5. Moreover, since the neoplasms located in the third layer of the DAG of DSN, then its semantic contribution to DSN is 0.5*0.5 = 0.25. Hence, according to above formula (2), it is easy to know the semantic value of DSN will be 2.25 (=1 + 0.5 + 0.5 + 0.25).</p>
        </sec>
        <sec id="FPar5">
          <title>Step 5</title>
          <p id="Par42">For any two given diseases <italic>d</italic><sub><italic>i</italic></sub> and <italic>d</italic><sub><italic>j</italic></sub>, based on the assumption that the more similar the structures of their DAGs, the higher the semantic similarity between them will be, the semantic similarity between <italic>d</italic><sub><italic>i</italic></sub> and <italic>d</italic><sub><italic>j</italic></sub> can be defined as follows:
<disp-formula id="Equ3"><label>3</label><alternatives><tex-math id="M17">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ DisSemSim\left(i,j\right)= DisSemSim\left({d}_i,{d}_j\right)=\frac{\sum_{t\in \left( DAG\left({d}_i\right)\cap DAG\left({d}_j\right)\right)}\left({D}_{d_i}(t)+{D}_{d_j}(t)\right)}{D\left({d}_i\right)+D\left({d}_j\right)} $$\end{document}</tex-math><mml:math id="M18" display="block"><mml:mtext mathvariant="italic">DisSemSim</mml:mtext><mml:mfenced close=")" open="(" separators=","><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mtext mathvariant="italic">DisSemSim</mml:mtext><mml:mfenced close=")" open="(" separators=","><mml:msub><mml:mi>d</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:msub><mml:mi>d</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mfenced><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mo>∑</mml:mo><mml:mrow><mml:mi>t</mml:mi><mml:mo>∈</mml:mo><mml:mfenced close=")" open="("><mml:mrow><mml:mi mathvariant="italic">DAG</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi>d</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mfenced><mml:mo>∩</mml:mo><mml:mi mathvariant="italic">DAG</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi>d</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mfenced></mml:mrow></mml:mfenced></mml:mrow></mml:msub><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mi>D</mml:mi><mml:msub><mml:mi>d</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:msub><mml:mfenced close=")" open="("><mml:mi>t</mml:mi></mml:mfenced><mml:mo>+</mml:mo><mml:msub><mml:mi>D</mml:mi><mml:msub><mml:mi>d</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:msub><mml:mfenced close=")" open="("><mml:mi>t</mml:mi></mml:mfenced></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mi>D</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi>d</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mfenced><mml:mo>+</mml:mo><mml:mi>D</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi>d</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mfenced></mml:mrow></mml:mfrac><mml:mspace width="0.25em"/></mml:math><graphic xlink:href="12859_2019_3216_Article_Equ3.gif" position="anchor"/></alternatives></disp-formula></p>
        </sec>
      </sec>
    </sec>
    <sec id="Sec13">
      <title>Gaussian interaction profile kernel similarity of diseases</title>
      <p id="Par43">Based on the assumption that similar diseases tend to be more likely associated with similar lncRNAs, according to above newly constructed lncRNA-disease association adjacency matrix <italic>A</italic>, for any two given diseases <italic>d</italic><sub><italic>i</italic></sub> and <italic>d</italic><sub><italic>j</italic></sub>, the Gaussian interaction profile kernel similarity between them can be obtained as follows:
<disp-formula id="Equ4"><label>4</label><alternatives><tex-math id="M19">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ GKD\left({d}_i,{d}_j\right)=\mathit{\exp}\left(-{\gamma}_d{\left\Vert IP\left({d}_i\right)- IP\left({d}_j\right)\right\Vert}^2\right) $$\end{document}</tex-math><mml:math id="M20" display="block"><mml:mi mathvariant="italic">GKD</mml:mi><mml:mfenced close=")" open="(" separators=","><mml:msub><mml:mi>d</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:msub><mml:mi>d</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mfenced><mml:mo>=</mml:mo><mml:mo mathvariant="italic">exp</mml:mo><mml:mfenced close=")" open="("><mml:mrow><mml:mo>−</mml:mo><mml:msub><mml:mi>γ</mml:mi><mml:mi>d</mml:mi></mml:msub><mml:msup><mml:mfenced close="‖" open="‖"><mml:mrow><mml:mi mathvariant="italic">IP</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi>d</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mfenced><mml:mo>−</mml:mo><mml:mi mathvariant="italic">IP</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi>d</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mfenced></mml:mrow></mml:mfenced><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfenced></mml:math><graphic xlink:href="12859_2019_3216_Article_Equ4.gif" position="anchor"/></alternatives></disp-formula>
<disp-formula id="Equ5"><label>5</label><alternatives><tex-math id="M21">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {\gamma}_d={\gamma}_d^{\hbox{'}}/\left({\sum \limits}_{k=1}^{N_D}{\left\Vert IP\left({d}_k\right)\right\Vert}^2\right) $$\end{document}</tex-math><mml:math id="M22" display="block"><mml:msub><mml:mi>γ</mml:mi><mml:mi>d</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:msubsup><mml:mi>γ</mml:mi><mml:mi>d</mml:mi><mml:mo>'</mml:mo></mml:msubsup><mml:mo>/</mml:mo><mml:mfenced close=")" open="("><mml:mrow><mml:msubsup><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:msub><mml:mi>N</mml:mi><mml:mi>D</mml:mi></mml:msub></mml:msubsup><mml:msup><mml:mfenced close="‖" open="‖"><mml:mrow><mml:mi mathvariant="italic">IP</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi>d</mml:mi><mml:mi>k</mml:mi></mml:msub></mml:mfenced></mml:mrow></mml:mfenced><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfenced></mml:math><graphic xlink:href="12859_2019_3216_Article_Equ5.gif" position="anchor"/></alternatives></disp-formula></p>
      <p id="Par44">Here, <italic>IP</italic>(<italic>d</italic><sub><italic>t</italic></sub>) denotes the vector consisting of elements in the <italic>t</italic>th row of the lncRNA-disease adjacency matrix <italic>A</italic>. <italic>γ</italic><sub><italic>d</italic></sub> is the parameter to control the kernel bandwidth based on the new bandwidth parameter <inline-formula id="IEq7"><alternatives><tex-math id="M23">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {\gamma}_d^{\prime } $$\end{document}</tex-math><mml:math id="M24" display="inline"><mml:msubsup><mml:mi>γ</mml:mi><mml:mi>d</mml:mi><mml:mo>′</mml:mo></mml:msubsup><mml:mspace width="0.25em"/></mml:math><inline-graphic xlink:href="12859_2019_3216_Article_IEq7.gif"/></alternatives></inline-formula>by computing the average number of lncRNAs-disease associations for all the diseases. In addition, inspired by the thoughts of former methods proposed by O. Vanunu et al. [<xref ref-type="bibr" rid="CR46">46</xref>], we will adopt a logistics function to optimize the Gaussian interaction profile kernel similarity between diseases, and based on above Equation (<xref rid="Equ4" ref-type="">4</xref>), we can further obtain a <italic>N</italic><sub><italic>D</italic></sub> × <italic>N</italic><sub><italic>D</italic></sub> dimensional adjacency matrix <italic>FKD</italic> as follows:
<disp-formula id="Equ6"><label>6</label><alternatives><tex-math id="M25">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ FKD\left(i,j\right)=\frac{1}{1+{e}^{\left(-12 GKD\left(i,j\right)+\log (9999)\right)}} $$\end{document}</tex-math><mml:math id="M26" display="block"><mml:mi mathvariant="italic">FKD</mml:mi><mml:mfenced close=")" open="(" separators=","><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msup><mml:mi>e</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:mo>−</mml:mo><mml:mn>12</mml:mn><mml:mi mathvariant="italic">GKD</mml:mi><mml:mfenced close=")" open="(" separators=","><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mfenced><mml:mo>+</mml:mo><mml:mo>log</mml:mo><mml:mfenced close=")" open="("><mml:mn>9999</mml:mn></mml:mfenced></mml:mrow></mml:mfenced></mml:msup></mml:mrow></mml:mfrac></mml:math><graphic xlink:href="12859_2019_3216_Article_Equ6.gif" position="anchor"/></alternatives></disp-formula></p>
    </sec>
    <sec id="Sec14">
      <title>Integrated similarity of diseases</title>
      <p id="Par45">Based on the disease semantic similarity and disease Gaussian interaction profile kernel similarity obtained above, a <italic>N</italic><sub><italic>D</italic></sub> × <italic>N</italic><sub><italic>D</italic></sub> dimensional integrated disease similarity adjacency matrix <italic>KD</italic> (<italic>N</italic><sub><italic>D</italic></sub> × <italic>N</italic><sub><italic>D</italic></sub>) can be obtained as follows:
<disp-formula id="Equ7"><label>7</label><alternatives><tex-math id="M27">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ KD\left(i,j\right)=\frac{DisSemSim\left(i,j\right)+ FKD\left(i,j\right)}{2} $$\end{document}</tex-math><mml:math id="M28" display="block"><mml:mi mathvariant="italic">KD</mml:mi><mml:mfenced close=")" open="(" separators=","><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mtext mathvariant="italic">DisSemSim</mml:mtext><mml:mfenced close=")" open="(" separators=","><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mfenced><mml:mo>+</mml:mo><mml:mi mathvariant="italic">FKD</mml:mi><mml:mfenced close=")" open="(" separators=","><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mfenced></mml:mrow><mml:mn>2</mml:mn></mml:mfrac></mml:math><graphic xlink:href="12859_2019_3216_Article_Equ7.gif" position="anchor"/></alternatives></disp-formula></p>
    </sec>
    <sec id="Sec15">
      <title>Similarity of LncRNAs</title>
      <sec id="Sec16">
        <title>Functional similarity of LncRNAs</title>
        <p id="Par46">We can obtain corresponding disease groups of two given lncRNAs <italic>l</italic><sub><italic>i</italic></sub> and <italic>l</italic><sub><italic>j</italic></sub> from the known associations of lncRNA-disease. Based on the assumption that similar diseases tend to be more likely associated with similar lncRNAs, We define the functional similarity of two given lncRNAs <italic>l</italic><sub><italic>i</italic></sub> and <italic>l</italic><sub><italic>j</italic></sub> as the semantic similarity between the disease groups corresponding to them. The specific calculation process is as follows:</p>
        <p id="Par47">For any two given lncRNAs <italic>l</italic><sub><italic>i</italic></sub> and <italic>l</italic><sub><italic>j</italic></sub>, let <italic>DS</italic>(<italic>i</italic>) = {<italic>d</italic><sub><italic>k</italic></sub> | <italic>A</italic>(<italic>k</italic>, <italic>i</italic>) = 1, <italic>k</italic>∈[1, <italic>N</italic><sub><italic>D</italic></sub>]} and <italic>DS</italic>(<italic>j</italic>) = {<italic>d</italic><sub><italic>k</italic></sub> | <italic>A</italic>(<italic>k</italic>, <italic>j</italic>) = 1, <italic>k</italic>∈[1, <italic>N</italic><sub><italic>D</italic></sub>]}, then the functional similarity between <italic>l</italic><sub><italic>i</italic></sub> and <italic>l</italic><sub><italic>j</italic></sub> can be calculated according to the following steps [<xref ref-type="bibr" rid="CR31">31</xref>]:</p>
        <sec id="FPar6">
          <title>Step 1</title>
          <p id="Par48">For any given disease group <italic>DS</italic>(<italic>k</italic>) and disease <italic>d</italic><sub><italic>t</italic></sub>∉<italic>DS</italic>(<italic>k</italic>), we first calculate the similarity between <italic>d</italic><sub><italic>t</italic></sub> and <italic>DS</italic>(<italic>k</italic>) as follows:
<disp-formula id="Equ8"><label>8</label><alternatives><tex-math id="M29">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ S\left({d}_t, DS(k)\right)={\max}_{d_s\in DS(k)}\left\{ DisSemSim\left({d}_t,{d}_s\right)\right\} $$\end{document}</tex-math><mml:math id="M30" display="block"><mml:mi>S</mml:mi><mml:mfenced close=")" open="(" separators=","><mml:msub><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mrow><mml:mi mathvariant="italic">DS</mml:mi><mml:mfenced close=")" open="("><mml:mi>k</mml:mi></mml:mfenced></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:msub><mml:mo>max</mml:mo><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo>∈</mml:mo><mml:mi mathvariant="italic">DS</mml:mi><mml:mfenced close=")" open="("><mml:mi>k</mml:mi></mml:mfenced></mml:mrow></mml:msub><mml:mfenced close="}" open="{"><mml:mrow><mml:mtext mathvariant="italic">DisSemSim</mml:mtext><mml:mfenced close=")" open="(" separators=","><mml:msub><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:msub><mml:mi>d</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mfenced></mml:mrow></mml:mfenced></mml:math><graphic xlink:href="12859_2019_3216_Article_Equ8.gif" position="anchor"/></alternatives></disp-formula></p>
        </sec>
        <sec id="FPar7">
          <title>Step 2</title>
          <p id="Par49">Therefore, based on above Equation (<xref rid="Equ8" ref-type="">8</xref>), we define the functional similarity between <italic>l</italic><sub><italic>i</italic></sub> and <italic>l</italic><sub><italic>j</italic></sub> as <italic>FuncKL</italic>(<italic>i</italic>, <italic>j</italic>), which can be calculated as follows:
<disp-formula id="Equ9"><label>9</label><alternatives><tex-math id="M31">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ FuncKL\left(i,j\right)=\frac{\sum_{d_t\in DS(i)}S\left({d}_t, DS(j)\right)+{\sum}_{d_t\in DS(j)}S\left({d}_t, DS(i)\right)}{\mid DS(i)\mid +\mid DS(i)\mid } $$\end{document}</tex-math><mml:math id="M32" display="block"><mml:mtext mathvariant="italic">FuncKL</mml:mtext><mml:mfenced close=")" open="(" separators=","><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mo>∑</mml:mo><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>∈</mml:mo><mml:mi mathvariant="italic">DS</mml:mi><mml:mfenced close=")" open="("><mml:mi>i</mml:mi></mml:mfenced></mml:mrow></mml:msub><mml:mi>S</mml:mi><mml:mfenced close=")" open="(" separators=","><mml:msub><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mrow><mml:mi mathvariant="italic">DS</mml:mi><mml:mfenced close=")" open="("><mml:mi>j</mml:mi></mml:mfenced></mml:mrow></mml:mfenced><mml:mo>+</mml:mo><mml:msub><mml:mo>∑</mml:mo><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>∈</mml:mo><mml:mi mathvariant="italic">DS</mml:mi><mml:mfenced close=")" open="("><mml:mi>j</mml:mi></mml:mfenced></mml:mrow></mml:msub><mml:mi>S</mml:mi><mml:mfenced close=")" open="(" separators=","><mml:msub><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mrow><mml:mi mathvariant="italic">DS</mml:mi><mml:mfenced close=")" open="("><mml:mi>i</mml:mi></mml:mfenced></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mo>∣</mml:mo><mml:mi mathvariant="italic">DS</mml:mi><mml:mfenced close=")" open="("><mml:mi>i</mml:mi></mml:mfenced><mml:mo>∣</mml:mo><mml:mo>+</mml:mo><mml:mo>∣</mml:mo><mml:mi mathvariant="italic">DS</mml:mi><mml:mfenced close=")" open="("><mml:mi>i</mml:mi></mml:mfenced><mml:mo>∣</mml:mo></mml:mrow></mml:mfrac></mml:math><graphic xlink:href="12859_2019_3216_Article_Equ9.gif" position="anchor"/></alternatives></disp-formula></p>
          <p id="Par50">Here, |<italic>D</italic>(<italic>i</italic>)| and |<italic>D</italic>(<italic>j</italic>)| represent the number of diseases in <italic>DS</italic>(<italic>i</italic>) and <italic>DS</italic>(<italic>j</italic>) respectively. Thereafter, according to above Equation (<xref rid="Equ9" ref-type="">9</xref>), it is obvious that a <italic>N</italic><sub><italic>L</italic></sub> × <italic>N</italic><sub><italic>L</italic></sub> dimensional lncRNA functional similarity matrix <italic>FuncKL</italic> can be obtained in final.</p>
        </sec>
      </sec>
    </sec>
    <sec id="Sec17">
      <title>Gaussian interaction profile kernel similarity of lncRNAs</title>
      <p id="Par51">Based on the assumption that similar lncRNAs tend to be more likely associated with similar diseases, according to above newly constructed lncRNA-disease association adjacency matrix <italic>A</italic>, for any two given lncRNAs <italic>l</italic><sub><italic>i</italic></sub> and <italic>l</italic><sub><italic>j</italic></sub>, the Gaussian interaction profile kernel similarity between them can be obtained as follows:
<disp-formula id="Equ10"><label>10</label><alternatives><tex-math id="M33">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ FKL\left({l}_i,{l}_j\right)=\mathit{\exp}\left(-{\gamma}_l{\left\Vert IP\left({l}_i\right)- IP\left({l}_j\right)\right\Vert}^2\right) $$\end{document}</tex-math><mml:math id="M34" display="block"><mml:mi mathvariant="italic">FKL</mml:mi><mml:mfenced close=")" open="(" separators=","><mml:msub><mml:mi>l</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:msub><mml:mi>l</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mfenced><mml:mo>=</mml:mo><mml:mo mathvariant="italic">exp</mml:mo><mml:mfenced close=")" open="("><mml:mrow><mml:mo>−</mml:mo><mml:msub><mml:mi>γ</mml:mi><mml:mi>l</mml:mi></mml:msub><mml:msup><mml:mfenced close="‖" open="‖"><mml:mrow><mml:mi mathvariant="italic">IP</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi>l</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mfenced><mml:mo>−</mml:mo><mml:mi mathvariant="italic">IP</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi>l</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mfenced></mml:mrow></mml:mfenced><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfenced></mml:math><graphic xlink:href="12859_2019_3216_Article_Equ10.gif" position="anchor"/></alternatives></disp-formula>
<disp-formula id="Equ11"><label>11</label><alternatives><tex-math id="M35">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {\gamma}_l={\gamma}_l^{\hbox{'}}/\left({\sum \limits}_{k=1}^{N_L}{\left\Vert IP\left({l}_k\right)\right\Vert}^2\right) $$\end{document}</tex-math><mml:math id="M36" display="block"><mml:msub><mml:mi>γ</mml:mi><mml:mi>l</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:msubsup><mml:mi>γ</mml:mi><mml:mi>l</mml:mi><mml:mo>'</mml:mo></mml:msubsup><mml:mo>/</mml:mo><mml:mfenced close=")" open="("><mml:mrow><mml:msubsup><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:msub><mml:mi>N</mml:mi><mml:mi>L</mml:mi></mml:msub></mml:msubsup><mml:msup><mml:mfenced close="‖" open="‖"><mml:mrow><mml:mi mathvariant="italic">IP</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi>l</mml:mi><mml:mi>k</mml:mi></mml:msub></mml:mfenced></mml:mrow></mml:mfenced><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfenced></mml:math><graphic xlink:href="12859_2019_3216_Article_Equ11.gif" position="anchor"/></alternatives></disp-formula></p>
      <p id="Par52">Here, <italic>IP</italic>(<italic>l</italic><sub><italic>t</italic></sub>) denotes the vector consisting of elements in the <italic>t</italic>th column of the lncRNA-disease adjacency matrix <italic>A</italic>. <italic>γ</italic><sub><italic>l</italic></sub> is the parameter to control the kernel bandwidth based on the new bandwidth parameter<inline-formula id="IEq8"><alternatives><tex-math id="M37">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {\gamma}_l^{\prime } $$\end{document}</tex-math><mml:math id="M38" display="inline"><mml:mspace width="0.25em"/><mml:msubsup><mml:mi>γ</mml:mi><mml:mi>l</mml:mi><mml:mo>′</mml:mo></mml:msubsup><mml:mspace width="0.25em"/></mml:math><inline-graphic xlink:href="12859_2019_3216_Article_IEq8.gif"/></alternatives></inline-formula>by computing the average number of lncRNAs-disease associations for all the lncRNAs. So far, based on above Equation (<xref rid="Equ10" ref-type="">10</xref>), we can obtain a <italic>N</italic><sub><italic>L</italic></sub> × <italic>N</italic><sub><italic>L</italic></sub> dimensional lncRNA Gaussian interaction profile kernel similarity matrix <italic>FKL</italic> as well.</p>
    </sec>
    <sec id="Sec18">
      <title>Integrated similarity of lncRNAs</title>
      <p id="Par53">Based on the lncRNA functional similarity and lncRNA Gaussian interaction profile kernel similarity obtained above, a <italic>N</italic><sub><italic>L</italic></sub> × <italic>N</italic><sub><italic>L</italic></sub> dimensional integrated lncRNA similarity adjacency matrix <italic>KL (N</italic><sub><italic>L</italic></sub> <italic>× N</italic><sub><italic>L</italic></sub><italic>)</italic> can be obtained as follows:
<disp-formula id="Equ12"><label>12</label><alternatives><tex-math id="M39">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ KL\left(i,j\right)=\frac{FuncKL\left(i,j\right)+ FKL\left(i,j\right)}{2} $$\end{document}</tex-math><mml:math id="M40" display="block"><mml:mi mathvariant="italic">KL</mml:mi><mml:mfenced close=")" open="(" separators=","><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mtext mathvariant="italic">FuncKL</mml:mtext><mml:mfenced close=")" open="(" separators=","><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mfenced><mml:mo>+</mml:mo><mml:mi mathvariant="italic">FKL</mml:mi><mml:mfenced close=")" open="(" separators=","><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mfenced></mml:mrow><mml:mn>2</mml:mn></mml:mfrac></mml:math><graphic xlink:href="12859_2019_3216_Article_Equ12.gif" position="anchor"/></alternatives></disp-formula></p>
    </sec>
    <sec id="Sec19">
      <title>Construction of computational model TCSRWRLD</title>
      <sec id="Sec20">
        <title>The establishment of heterogeneous network</title>
        <p id="Par54">Through combing the <italic>N</italic><sub><italic>D</italic></sub> × <italic>N</italic><sub><italic>D</italic></sub> dimensional integrated disease similarity adjacency matrix <italic>KD</italic> and the <italic>N</italic><sub><italic>L</italic></sub> × <italic>N</italic><sub><italic>L</italic></sub> dimensional integrated lncRNA similarity adjacency matrix <italic>KL</italic> with the <italic>N</italic><sub><italic>D</italic></sub> × <italic>N</italic><sub><italic>L</italic></sub> dimensional lncRNA-disease association adjacency matrix <italic>A</italic>, we can construct a new (<italic>N</italic><sub><italic>L</italic></sub> + <italic>N</italic><sub><italic>D</italic></sub>) × (<italic>N</italic><sub><italic>L</italic></sub> + <italic>N</italic><sub><italic>D</italic></sub>) dimensional integrated matrix <italic>AA</italic> as follow:
<disp-formula id="Equ13"><label>13</label><alternatives><tex-math id="M41">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ AA\left(i,j\right)=\left[\begin{array}{cc} KL\left(i,j\right)&amp; {A}^T\left(i,j\right)\\ {}A\left(i,j\right)&amp; KD\left(i,j\right)\end{array}\right] $$\end{document}</tex-math><mml:math id="M42" display="block"><mml:mi mathvariant="italic">AA</mml:mi><mml:mfenced close=")" open="(" separators=","><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mfenced close="]" open="[" separators=","><mml:mtable><mml:mtr><mml:mtd><mml:mi mathvariant="italic">KL</mml:mi><mml:mfenced close=")" open="(" separators=","><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mfenced></mml:mtd><mml:mtd><mml:msup><mml:mi>A</mml:mi><mml:mi>T</mml:mi></mml:msup><mml:mfenced close=")" open="(" separators=","><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mfenced></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mi>A</mml:mi><mml:mfenced close=")" open="(" separators=","><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mfenced></mml:mtd><mml:mtd><mml:mi mathvariant="italic">KD</mml:mi><mml:mfenced close=")" open="(" separators=","><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mfenced></mml:mtd></mml:mtr></mml:mtable></mml:mfenced></mml:math><graphic xlink:href="12859_2019_3216_Article_Equ13.gif" position="anchor"/></alternatives></disp-formula></p>
        <p id="Par55">According to above Equation (<xref rid="Equ13" ref-type="">13</xref>), we can construct a corresponding heterogeneous lncRNA-disease network consisting of <italic>N</italic><sub><italic>D</italic></sub> different disease nodes and <italic>N</italic><sub><italic>L</italic></sub> different lncRNA nodes, in which, for any given pair of nodes <italic>i</italic> and <italic>j</italic>, there is an edge existing between them, if and only if there is <italic>AA</italic>(<italic>i</italic>, <italic>j</italic>) &gt; 0.</p>
      </sec>
      <sec id="Sec21">
        <title>Establishment of TCS (target convergence set)</title>
        <p id="Par56">Before the implementation of random walk, for each node in above newly constructed heterogeneous lncRNA-disease network, as illustrated in Fig. <xref rid="Fig6" ref-type="fig">6</xref>, it will establish its own TCS first according to the following steps:
<fig id="Fig6"><label>Fig. 6</label><caption><p>Flow chart of constructing TCS for an lncRNA node <italic>j</italic></p></caption><graphic xlink:href="12859_2019_3216_Fig6_HTML" id="MO6"/></fig></p>
        <sec id="FPar8">
          <title>Step 1</title>
          <p id="Par57">For any given lncRNA node <italic>l</italic><sub><italic>j</italic></sub>, we define its original TCS as the set of all disease nodes that have known associations with it, i.e., the original TCS of <italic>l</italic><sub><italic>j</italic></sub> is <italic>TCS</italic><sub>0</sub>(<italic>l</italic><sub><italic>j</italic></sub>) = {<italic>d</italic><sub><italic>k</italic></sub> | <italic>A</italic>(<italic>k</italic>, <italic>j</italic>) = 1, <italic>k</italic>∈[1, <italic>N</italic><sub><italic>D</italic></sub>]}. Similarly, for a given disease node <italic>d</italic><sub><italic>i</italic></sub>, we can define its original <italic>TCS</italic> as <italic>TCS</italic><sub>0</sub>(<italic>d</italic><sub><italic>i</italic></sub>) = {<italic>l</italic><sub><italic>k</italic></sub> | <italic>A</italic>(<italic>i</italic>, <italic>k</italic>) = 1, <italic>k</italic>∈[1, <italic>N</italic><sub><italic>L</italic></sub>]}.</p>
        </sec>
        <sec id="FPar9">
          <title>Step 2</title>
          <p id="Par58">After the original TCS has been established, for any given lncRNA node <italic>l</italic><sub><italic>j</italic></sub>, ∀<italic>d</italic><sub><italic>k</italic></sub>∈<italic>TCS</italic><sub>0</sub>(<italic>l</italic><sub><italic>j</italic></sub>), and ∀<italic>t</italic>∈[1, <italic>N</italic><sub><italic>D</italic></sub>], then we can define the network distance <italic>ND</italic>(<italic>k</italic>, <italic>t</italic>) between <italic>d</italic><sub><italic>k</italic></sub> and <italic>d</italic><sub><italic>t</italic></sub> as follows:
<disp-formula id="Equ14"><label>14</label><alternatives><tex-math id="M43">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ ND\left(k,t\right)=\frac{1}{KD\left(k,t\right)} $$\end{document}</tex-math><mml:math id="M44" display="block"><mml:mi mathvariant="italic">ND</mml:mi><mml:mfenced close=")" open="(" separators=","><mml:mi>k</mml:mi><mml:mi>t</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:mi mathvariant="italic">KD</mml:mi><mml:mfenced close=")" open="(" separators=","><mml:mi>k</mml:mi><mml:mi>t</mml:mi></mml:mfenced></mml:mrow></mml:mfrac></mml:math><graphic xlink:href="12859_2019_3216_Article_Equ14.gif" position="anchor"/></alternatives></disp-formula></p>
          <p id="Par59">According to above Equation (<xref rid="Equ14" ref-type="">14</xref>), for any disease nodes <italic>d</italic><sub><italic>k</italic></sub>∈<italic>TCS</italic><sub>0</sub>(<italic>l</italic><sub><italic>j</italic></sub>) and ∀<italic>t</italic>∈[1, <italic>N</italic><sub><italic>D</italic></sub>], obviously it is reasonable to deduce that the smaller the value of <italic>ND</italic>(<italic>k</italic>, <italic>t</italic>), the higher the similarity between <italic>d</italic><sub><italic>t</italic></sub> and <italic>d</italic><sub><italic>k</italic></sub> would be, i.e., the higher the possibility that there is potential association between <italic>d</italic><sub><italic>t</italic></sub> and <italic>l</italic><sub><italic>j</italic></sub> will be.</p>
          <p id="Par60">Similarly, for any given disease node <italic>d</italic><sub><italic>i</italic></sub>, ∀<italic>l</italic><sub><italic>k</italic></sub>∈<italic>TCS</italic><sub>0</sub>(<italic>d</italic><sub><italic>i</italic></sub>) and ∀<italic>t</italic>∈[1, <italic>N</italic><sub><italic>L</italic></sub>], we can define the network distance <italic>ND</italic>(<italic>k</italic>, <italic>t</italic>) between <italic>l</italic><sub><italic>k</italic></sub> and <italic>l</italic><sub><italic>t</italic></sub> as follows:
<disp-formula id="Equ15"><label>15</label><alternatives><tex-math id="M45">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ ND\left(k,t\right)=\frac{1}{KL\left(k,t\right)} $$\end{document}</tex-math><mml:math id="M46" display="block"><mml:mi mathvariant="italic">ND</mml:mi><mml:mfenced close=")" open="(" separators=","><mml:mi>k</mml:mi><mml:mi>t</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:mi mathvariant="italic">KL</mml:mi><mml:mfenced close=")" open="(" separators=","><mml:mi>k</mml:mi><mml:mi>t</mml:mi></mml:mfenced></mml:mrow></mml:mfrac></mml:math><graphic xlink:href="12859_2019_3216_Article_Equ15.gif" position="anchor"/></alternatives></disp-formula></p>
          <p id="Par61">According to above Equation (<xref rid="Equ15" ref-type="">15</xref>), for any lncRNA nodes <italic>l</italic><sub><italic>k</italic></sub>∈<italic>TCS</italic><sub>0</sub>(<italic>d</italic><sub><italic>i</italic></sub>) and ∀<italic>t</italic>∈[1, <italic>N</italic><sub><italic>L</italic></sub>], obviously it is reasonable to deduce that the smaller the value of <italic>ND</italic>(<italic>k</italic>, <italic>t</italic>), the higher the similarity between <italic>l</italic><sub><italic>t</italic></sub> and <italic>l</italic><sub><italic>k</italic></sub> will be, i.e., the higher the possibility that there is potential association between <italic>l</italic><sub><italic>t</italic></sub> and <italic>d</italic><sub><italic>i</italic></sub> will be.</p>
        </sec>
        <sec id="FPar10">
          <title>Step 3</title>
          <p id="Par62">According to above Equation (<xref rid="Equ14" ref-type="">14</xref>) and Equation (<xref rid="Equ15" ref-type="">15</xref>), for any given disease node <italic>d</italic><sub><italic>i</italic></sub> or any given lncRNA node <italic>l</italic><sub><italic>j</italic></sub>, we define that the TCS of <italic>d</italic><sub><italic>i</italic></sub> as the set of top 100 lncRNA nodes in the heterogeneous lncRNA-disease network that have minimum average network distance to the lncRNA nodes in <italic>TCS</italic><sub>0</sub>(<italic>d</italic><sub><italic>i</italic></sub>), and the TCS of <italic>l</italic><sub><italic>j</italic></sub> as the set of top 100 disease nodes in the heterogeneous lncRNA-disease network that have minimum average network distance to the disease nodes in <italic>TCS</italic><sub>0</sub>(<italic>l</italic><sub><italic>j</italic></sub>). Then, it is easy to know that these 100 lncRNA nodes in <italic>TCS</italic> (<italic>d</italic><sub><italic>i</italic></sub>) may belong to <italic>TCS</italic><sub>0</sub>(<italic>d</italic><sub><italic>i</italic></sub>) or may not belong to <italic>TCS</italic><sub>0</sub>(<italic>d</italic><sub><italic>i</italic></sub>), and these 100 disease nodess in <italic>TCS</italic> (<italic>l</italic><sub><italic>j</italic></sub>) may belong to <italic>TCS</italic><sub>0</sub>(<italic>l</italic><sub><italic>j</italic></sub>) or may not belong to <italic>TCS</italic><sub>0</sub>(<italic>l</italic><sub><italic>j</italic></sub>).</p>
        </sec>
      </sec>
      <sec id="Sec22">
        <title>Random walk in the heterogeneous LncRNA-disease network</title>
        <p id="Par63">The method of random walk simulates the process of random walker’s transition from one starting node to other neighboring nodes in the network with given probability. Based on the assumption that similar diseases tend to be more likely associated with similar lncRNAs, as illustrated in Fig. <xref rid="Fig7" ref-type="fig">7</xref>, the process of our prediction model TCSRWRLD can be divided into the following major steps:
<fig id="Fig7"><label>Fig. 7</label><caption><p>Flow chart of our prediction model TCSRWRLD</p></caption><graphic xlink:href="12859_2019_3216_Fig7_HTML" id="MO7"/></fig></p>
        <sec id="FPar11">
          <title>Step 1</title>
          <p id="Par64">For a walker, before it starts its random walk across the heterogeneous lncRNA-disease network, it will first construct a transition probability matrix <italic>W</italic> as follows:
<disp-formula id="Equ16"><label>16</label><alternatives><tex-math id="M47">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ W\left(i,j\right)=\frac{AA\left(i,j\right)}{\sum_{k=1}^{N_D+{N}_L} AA\left(i,k\right)} $$\end{document}</tex-math><mml:math id="M48" display="block"><mml:mi>W</mml:mi><mml:mfenced close=")" open="(" separators=","><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi mathvariant="italic">AA</mml:mi><mml:mfenced close=")" open="(" separators=","><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mfenced></mml:mrow><mml:mrow><mml:msubsup><mml:mo>∑</mml:mo><mml:mrow><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:msub><mml:mi>N</mml:mi><mml:mi>D</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mi>L</mml:mi></mml:msub></mml:mrow></mml:msubsup><mml:mi mathvariant="italic">AA</mml:mi><mml:mfenced close=")" open="(" separators=","><mml:mi>i</mml:mi><mml:mi>k</mml:mi></mml:mfenced></mml:mrow></mml:mfrac></mml:math><graphic xlink:href="12859_2019_3216_Article_Equ16.gif" position="anchor"/></alternatives></disp-formula></p>
        </sec>
        <sec id="FPar12">
          <title>Step 2</title>
          <p id="Par65">In addition, for any node <italic>£</italic><sub><italic>i</italic></sub> in the heterogeneous lncRNA-disease network, whether <italic>£</italic><sub><italic>i</italic></sub> is a lncRNA node <italic>l</italic><sub><italic>i</italic></sub> or a disease node <italic>d</italic><sub><italic>i</italic></sub>, it can obtain an initial probability vector <italic>P</italic><sub><italic>i</italic></sub> (0) for itself as follows:
<disp-formula id="Equ17"><label>17</label><alternatives><tex-math id="M49">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {P}_i(0)={\left({p}_{i,1}(0),{p}_{i,2}(0),\dots, {p}_{i,j}(0),\dots {p}_{i,{N}_D+{N}_L}(0)\right)}^T $$\end{document}</tex-math><mml:math id="M50" display="block"><mml:msub><mml:mi>P</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mfenced close=")" open="("><mml:mn>0</mml:mn></mml:mfenced><mml:mo>=</mml:mo><mml:msup><mml:mfenced close=")" open="(" separators=",,,,"><mml:mrow><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfenced close=")" open="("><mml:mn>0</mml:mn></mml:mfenced></mml:mrow><mml:mrow><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mfenced close=")" open="("><mml:mn>0</mml:mn></mml:mfenced></mml:mrow><mml:mo>…</mml:mo><mml:mrow><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mfenced close=")" open="("><mml:mn>0</mml:mn></mml:mfenced></mml:mrow><mml:mrow><mml:mo>…</mml:mo><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mi>D</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mi>L</mml:mi></mml:msub></mml:mrow></mml:msub><mml:mfenced close=")" open="("><mml:mn>0</mml:mn></mml:mfenced></mml:mrow></mml:mfenced><mml:mi>T</mml:mi></mml:msup></mml:math><graphic xlink:href="12859_2019_3216_Article_Equ17.gif" position="anchor"/></alternatives></disp-formula>
<disp-formula id="Equ18"><label>18</label><alternatives><tex-math id="M51">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {p}_{i,j}(0)=W\left(i,j\right)\kern0.36em j=1,2,\dots, {N}_{D+}{N}_L $$\end{document}</tex-math><mml:math id="M52" display="block"><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mfenced close=")" open="("><mml:mn>0</mml:mn></mml:mfenced><mml:mo>=</mml:mo><mml:mi>W</mml:mi><mml:mfenced close=")" open="(" separators=","><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mfenced><mml:mspace width="0.24em"/><mml:malignmark/><mml:mspace width="0.12em"/><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mrow><mml:mi>D</mml:mi><mml:mo>+</mml:mo></mml:mrow></mml:msub><mml:msub><mml:mi>N</mml:mi><mml:mi>L</mml:mi></mml:msub></mml:math><graphic xlink:href="12859_2019_3216_Article_Equ18.gif" position="anchor"/></alternatives></disp-formula></p>
        </sec>
        <sec id="FPar13">
          <title>Step 3</title>
          <p id="Par66">Next, the walker will randomly select a node <italic>§</italic><sub><italic>i</italic></sub> in the heterogeneous lncRNA-disease network as the starting node to initiate its random walk, where <italic>§</italic><sub><italic>i</italic></sub> may be an lncRNA node <italic>l</italic><sub><italic>i</italic></sub> or a disease node <italic>d</italic><sub><italic>i</italic></sub>. After the initiation of the random walk process, supposing that currently the walker has arrived at the node <italic>Γ</italic><sub><italic>i</italic></sub> from the previous hop node <italic>Γ</italic><sub><italic>j</italic></sub> after <italic>t</italic>-1 hops during its random walk across the heterogeneous lncRNA-disease network, then here and now, whether <italic>Γ</italic><sub><italic>i</italic></sub> is a lncRNA node <italic>l</italic><sub><italic>i</italic></sub> or a disease node <italic>d</italic><sub><italic>i</italic></sub>, and <italic>Γ</italic><sub><italic>j</italic></sub> is a lncRNA node <italic>l</italic><sub><italic>j</italic></sub> or a disease node <italic>d</italic><sub><italic>j</italic></sub>, the walker can further obtain a walking probability vector <italic>P</italic><sub><italic>i</italic></sub>(<italic>t</italic>) as follows:
<disp-formula id="Equ19"><label>19</label><alternatives><tex-math id="M53">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {P}_i(t)=\left(1-\partial \right)\ast {W}^T\ast {P}_j\left(t-1\right)+\partial \ast {P}_i(0) $$\end{document}</tex-math><mml:math id="M54" display="block"><mml:msub><mml:mi>P</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mfenced close=")" open="("><mml:mi>t</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mfenced close=")" open="("><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mi>∂</mml:mi></mml:mrow></mml:mfenced><mml:mo>∗</mml:mo><mml:msup><mml:mi>W</mml:mi><mml:mi>T</mml:mi></mml:msup><mml:mo>∗</mml:mo><mml:msub><mml:mi>P</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mfenced close=")" open="("><mml:mrow><mml:mi>t</mml:mi><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mfenced><mml:mo>+</mml:mo><mml:mi>∂</mml:mi><mml:mo>∗</mml:mo><mml:msub><mml:mi>P</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mfenced close=")" open="("><mml:mn>0</mml:mn></mml:mfenced></mml:math><graphic xlink:href="12859_2019_3216_Article_Equ19.gif" position="anchor"/></alternatives></disp-formula></p>
          <p id="Par67">Where <italic>∂</italic> (0&lt; <italic>∂</italic>&lt; 1) is a parameter for the walker to adjust the value of walking probability vector at each hop. Moreover, based on above newly obtained walking probability vector <italic>P</italic><sub><italic>i</italic></sub>(<italic>t</italic>), let <italic>P</italic><sub><italic>i</italic></sub>(<italic>t</italic>) =<inline-formula id="IEq9"><alternatives><tex-math id="M55">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {\left({p}_{i,1}(t),{p}_{i,2}(t),\dots, {p}_{i,j}(t),\dots {p}_{i,{N}_D+{N}_L}(t)\right)}^T $$\end{document}</tex-math><mml:math id="M56" display="inline"><mml:msup><mml:mfenced close=")" open="(" separators=",,,,"><mml:mrow><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfenced close=")" open="("><mml:mi>t</mml:mi></mml:mfenced></mml:mrow><mml:mrow><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mfenced close=")" open="("><mml:mi>t</mml:mi></mml:mfenced></mml:mrow><mml:mo>…</mml:mo><mml:mrow><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mfenced close=")" open="("><mml:mi>t</mml:mi></mml:mfenced></mml:mrow><mml:mrow><mml:mo>…</mml:mo><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mi>D</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mi>L</mml:mi></mml:msub></mml:mrow></mml:msub><mml:mfenced close=")" open="("><mml:mi>t</mml:mi></mml:mfenced></mml:mrow></mml:mfenced><mml:mi>T</mml:mi></mml:msup></mml:math><inline-graphic xlink:href="12859_2019_3216_Article_IEq9.gif"/></alternatives></inline-formula>, and for convenience, supposing that there is <italic>p</italic><sub><italic>i</italic>, <italic>k</italic></sub>(<italic>k</italic>)=maximum{<inline-formula id="IEq10"><alternatives><tex-math id="M57">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {p}_{i,1}(t),{p}_{i,2}(t),\dots, {p}_{i,k}(t),\dots {p}_{i,{N}_D+{N}_L}(t) $$\end{document}</tex-math><mml:math id="M58" display="inline"><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfenced close=")" open="("><mml:mi>t</mml:mi></mml:mfenced><mml:mo>,</mml:mo><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mfenced close=")" open="("><mml:mi>t</mml:mi></mml:mfenced><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mfenced close=")" open="("><mml:mi>t</mml:mi></mml:mfenced><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mi>D</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mi>L</mml:mi></mml:msub></mml:mrow></mml:msub><mml:mfenced close=")" open="("><mml:mi>t</mml:mi></mml:mfenced></mml:math><inline-graphic xlink:href="12859_2019_3216_Article_IEq10.gif"/></alternatives></inline-formula>}, then the walker will choose the node <italic>ψ</italic><sub><italic>k</italic></sub> as its next hop node, where <italic>ψ</italic><sub><italic>k</italic></sub> may be a lncRNA node <italic>l</italic><sub><italic>k</italic></sub> or a disease node <italic>d</italic><sub><italic>k</italic></sub>. Especially, as for the starting node <italic>§</italic><sub><italic>i</italic></sub>, since it can be regarded that the walker has arrived at <italic>§</italic><sub><italic>i</italic></sub> from <italic>§</italic><sub><italic>i</italic></sub> after 0 hops, then it is obvious that at the starting node <italic>§</italic><sub><italic>i</italic></sub>, the walker will obtain two kinds of probability vectors such as the initial probability vector <italic>P</italic><sub><italic>i</italic></sub> (0) and the walking probability vector <italic>P</italic><sub><italic>i</italic></sub> (1). However, at each intermediate node <italic>Γ</italic><sub><italic>i</italic></sub>, the walker will obtain two other kinds of probability vectors such as the initial probability vector <italic>P</italic><sub><italic>i</italic></sub> (0) and the walking probability vector <italic>P</italic><sub><italic>i</italic></sub>(<italic>t</italic>).</p>
        </sec>
        <sec id="FPar14">
          <title>Step 4</title>
          <p id="Par68">Based on above Equation (<xref rid="Equ19" ref-type="">19</xref>), supposing that currently the walker has arrived at the node <italic>Γ</italic><sub><italic>i</italic></sub> from the previous hop node <italic>Γ</italic><sub><italic>j</italic></sub> after <italic>t</italic>-1 hops during its random walk across the heterogeneous lncRNA-disease network, let the walking probability vectors obtained by the walker at the node <italic>Γ</italic><sub><italic>i</italic></sub> and <italic>Γ</italic><sub><italic>j</italic></sub> be <italic>P</italic><sub><italic>i</italic></sub>(<italic>t</italic>) and <italic>P</italic><sub><italic>j</italic></sub>(<italic>t</italic>-1) respectively, if the L1 norm between <italic>P</italic><sub><italic>i</italic></sub>(<italic>t</italic>) and <italic>P</italic><sub><italic>j</italic></sub>(<italic>t</italic>-1) satisfies ‖<italic>P</italic><sub><italic>i</italic></sub>(<italic>t</italic>) − <italic>P</italic><sub><italic>j</italic></sub>(<italic>t</italic> − 1)‖<sub>1</sub> ≤ 10<sup>−6</sup>, then we will regard that the walking probability vector <italic>P</italic><sub><italic>i</italic></sub>(<italic>t</italic>) has reached a stable state at the node <italic>Γ</italic><sub><italic>i</italic></sub>. Thus, after the walking probability vectors obtained by the walker at every disease node and lncRNA node in the heterogeneous lncRNA-disease network have reached stable state, and for convenience, let these stable walking probability vectors be <inline-formula id="IEq11"><alternatives><tex-math id="M59">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {P}_1\left(\infty \right),{P}_2\left(\infty \right),\dots, {P}_{N_D+{N}_L}\left(\infty \right) $$\end{document}</tex-math><mml:math id="M60" display="inline"><mml:msub><mml:mi>P</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mfenced close=")" open="("><mml:mo>∞</mml:mo></mml:mfenced><mml:mo>,</mml:mo><mml:msub><mml:mi>P</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mfenced close=")" open="("><mml:mo>∞</mml:mo></mml:mfenced><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:msub><mml:mi>N</mml:mi><mml:mi>D</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mi>L</mml:mi></mml:msub></mml:mrow></mml:msub><mml:mfenced close=")" open="("><mml:mo>∞</mml:mo></mml:mfenced></mml:math><inline-graphic xlink:href="12859_2019_3216_Article_IEq11.gif"/></alternatives></inline-formula>, then based on these stable walking probability vectors, we can obtain a stable walking probability matrix <italic>S</italic>(∞) as follows:
<disp-formula id="Equ20"><label>20</label><alternatives><tex-math id="M61">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ S\left(\infty \right)=\left[\frac{S_1}{S_3}\kern1em \frac{S_2}{S_4}\right]={\left({P}_1\left(\infty \right),{P}_2\left(\infty \right),\dots, {P}_{N_D+{N}_L}\left(\infty \right)\right)}^T $$\end{document}</tex-math><mml:math id="M62" display="block"><mml:mi>S</mml:mi><mml:mfenced close=")" open="("><mml:mo>∞</mml:mo></mml:mfenced><mml:mo>=</mml:mo><mml:mfenced close="]" open="["><mml:mrow><mml:mfrac><mml:msub><mml:mi>S</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:msub><mml:mi>S</mml:mi><mml:mn>3</mml:mn></mml:msub></mml:mfrac><mml:mspace width="1em"/><mml:mfrac><mml:msub><mml:mi>S</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mi>S</mml:mi><mml:mn>4</mml:mn></mml:msub></mml:mfrac></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:msup><mml:mfenced close=")" open="(" separators=",,,"><mml:mrow><mml:msub><mml:mi>P</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mfenced close=")" open="("><mml:mo>∞</mml:mo></mml:mfenced></mml:mrow><mml:mrow><mml:msub><mml:mi>P</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mfenced close=")" open="("><mml:mo>∞</mml:mo></mml:mfenced></mml:mrow><mml:mo>…</mml:mo><mml:mrow><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:msub><mml:mi>N</mml:mi><mml:mi>D</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mi>L</mml:mi></mml:msub></mml:mrow></mml:msub><mml:mfenced close=")" open="("><mml:mo>∞</mml:mo></mml:mfenced></mml:mrow></mml:mfenced><mml:mi>T</mml:mi></mml:msup></mml:math><graphic xlink:href="12859_2019_3216_Article_Equ20.gif" position="anchor"/></alternatives></disp-formula></p>
          <p id="Par69">Where <italic>S</italic><sub>1</sub> is a <italic>N</italic><sub><italic>L</italic></sub>×<italic>N</italic><sub><italic>L</italic></sub> dimensional matrix, <italic>S</italic><sub>2</sub> is a <italic>N</italic><sub><italic>L</italic></sub>×<italic>N</italic><sub><italic>D</italic></sub> dimensional matrix, <italic>S</italic><sub>3</sub> is a <italic>N</italic><sub><italic>D</italic></sub>×<italic>N</italic><sub><italic>L</italic></sub> dimensional matrix, and <italic>S</italic><sub>4</sub> is a <italic>N</italic><sub><italic>D</italic></sub>×<italic>N</italic><sub><italic>D</italic></sub> dimensional matrix. And moreover, from above descriptions, it is easy to infer that the matrix <italic>S</italic><sub>2</sub> and the matrix <italic>S</italic><sub>3</sub> are the final result matrices needed by us, and we can predict potential lncRNA-disease associations based on the scores given in these two final result matrices.</p>
          <p id="Par70">According to above described steps of the random walk process based on our prediction model TCSRWRLD, it is obvious that for each node <italic>Γ</italic><sub><italic>i</italic></sub> in the heterogeneous lncRNA-disease network, the stable walking probability vector obtained by the walker at <italic>Γ</italic><sub><italic>i</italic></sub> is <italic>P</italic><sub><italic>i</italic></sub>(∞) = <inline-formula id="IEq12"><alternatives><tex-math id="M63">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {\left({p}_{i,1}\left(\infty \right),{p}_{i,2}\left(\infty \right),\dots, {p}_{i,j}\left(\infty \right),\dots {p}_{i,{N}_D+{N}_L}\left(\infty \right)\right)}^T $$\end{document}</tex-math><mml:math id="M64" display="inline"><mml:msup><mml:mfenced close=")" open="(" separators=",,,,"><mml:mrow><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfenced close=")" open="("><mml:mo>∞</mml:mo></mml:mfenced></mml:mrow><mml:mrow><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mfenced close=")" open="("><mml:mo>∞</mml:mo></mml:mfenced></mml:mrow><mml:mo>…</mml:mo><mml:mrow><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mfenced close=")" open="("><mml:mo>∞</mml:mo></mml:mfenced></mml:mrow><mml:mrow><mml:mo>…</mml:mo><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mi>D</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mi>L</mml:mi></mml:msub></mml:mrow></mml:msub><mml:mfenced close=")" open="("><mml:mo>∞</mml:mo></mml:mfenced></mml:mrow></mml:mfenced><mml:mi>T</mml:mi></mml:msup></mml:math><inline-graphic xlink:href="12859_2019_3216_Article_IEq12.gif"/></alternatives></inline-formula>. Moreover, for convenience, we denote a node set consisting of all the <italic>N</italic><sub><italic>D</italic></sub>+<italic>N</italic><sub><italic>L</italic></sub> nodes in the heterogeneous lncRNA-disease network as a Global Set (<italic>GS</italic>), then it is obvious that we can rewrite the stable walking probability vector <italic>P</italic><sub><italic>i</italic></sub>(∞) as <inline-formula id="IEq13"><alternatives><tex-math id="M65">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {P}_i^{GS}\left(\infty \right) $$\end{document}</tex-math><mml:math id="M66" display="inline"><mml:msubsup><mml:mi>P</mml:mi><mml:mi>i</mml:mi><mml:mi mathvariant="italic">GS</mml:mi></mml:msubsup><mml:mfenced close=")" open="("><mml:mo>∞</mml:mo></mml:mfenced></mml:math><inline-graphic xlink:href="12859_2019_3216_Article_IEq13.gif"/></alternatives></inline-formula>. Additionally, from observing the stable walking probability vector <inline-formula id="IEq14"><alternatives><tex-math id="M67">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {P}_i^{GS}\left(\infty \right) $$\end{document}</tex-math><mml:math id="M68" display="inline"><mml:msubsup><mml:mi>P</mml:mi><mml:mi>i</mml:mi><mml:mi mathvariant="italic">GS</mml:mi></mml:msubsup><mml:mfenced close=")" open="("><mml:mo>∞</mml:mo></mml:mfenced></mml:math><inline-graphic xlink:href="12859_2019_3216_Article_IEq14.gif"/></alternatives></inline-formula>, it is easy to know that the walker will not stop its random walk until the <italic>N</italic><sub><italic>D</italic></sub>+<italic>N</italic><sub><italic>L</italic></sub> dimensional walking probability vector at each node in the heterogeneous lncRNA-disease network has reached a stable state, which will obviously be very time-consuming while the value of <italic>N</italic><sub><italic>D</italic></sub>+<italic>N</italic><sub><italic>L</italic></sub> is large to a certain extent. Hence, in order to decrease the execution time and quicken the velocity of convergence of TCSRWRLD, based on the concept of TCS proposed in above section, while constructing the walking probability vector <italic>P</italic><sub><italic>i</italic></sub>(<italic>t</italic>)=(<italic>p</italic><sub><italic>i</italic>, 1</sub>(<italic>t</italic>), <italic>p</italic><sub><italic>i</italic>, 2</sub>(<italic>t</italic>), …, <italic>p</italic><sub><italic>i</italic>, <italic>j</italic></sub>(<italic>t</italic>), <inline-formula id="IEq15"><alternatives><tex-math id="M69">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \dots, {p}_{i,{N}_D+{N}_L}(t)\Big){}^T $$\end{document}</tex-math><mml:math id="M70" display="inline"><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mi>D</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mi>L</mml:mi></mml:msub></mml:mrow></mml:msub><mml:mfenced close=")" open="("><mml:mi>t</mml:mi></mml:mfenced><mml:mo stretchy="true">)</mml:mo><mml:msup><mml:mrow/><mml:mi>T</mml:mi></mml:msup></mml:math><inline-graphic xlink:href="12859_2019_3216_Article_IEq15.gif"/></alternatives></inline-formula> at the node <italic>Γ</italic><sub><italic>i</italic></sub>, we will keep the <italic>p</italic><sub><italic>i</italic>, <italic>j</italic></sub>(<italic>t</italic>) unchanged if the <italic>j</italic>th node in these <italic>N</italic><sub><italic>D</italic></sub>+<italic>N</italic><sub><italic>L</italic></sub> nodes belongs to the TCS of <italic>Γ</italic><sub><italic>i</italic></sub>, otherwise we will set <italic>p</italic><sub><italic>i</italic>, <italic>j</italic></sub>(<italic>t</italic>)=0. Thus, the walking probability vector obtained by the walker at <italic>Γ</italic><sub><italic>i</italic></sub> will turn to be <inline-formula id="IEq16"><alternatives><tex-math id="M71">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {P}_i^{TCS}(t) $$\end{document}</tex-math><mml:math id="M72" display="inline"><mml:msubsup><mml:mi>P</mml:mi><mml:mi>i</mml:mi><mml:mi mathvariant="italic">TCS</mml:mi></mml:msubsup><mml:mfenced close=")" open="("><mml:mi>t</mml:mi></mml:mfenced></mml:math><inline-graphic xlink:href="12859_2019_3216_Article_IEq16.gif"/></alternatives></inline-formula> while the stable walking probability vector obtained by the walker at <italic>Γ</italic><sub><italic>i</italic></sub> will turn to be <inline-formula id="IEq17"><alternatives><tex-math id="M73">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {P}_i^{TCS}\left(\infty \right) $$\end{document}</tex-math><mml:math id="M74" display="inline"><mml:msubsup><mml:mi>P</mml:mi><mml:mi>i</mml:mi><mml:mi mathvariant="italic">TCS</mml:mi></mml:msubsup><mml:mfenced close=")" open="("><mml:mo>∞</mml:mo></mml:mfenced></mml:math><inline-graphic xlink:href="12859_2019_3216_Article_IEq17.gif"/></alternatives></inline-formula>. Obviously, comapred with <inline-formula id="IEq18"><alternatives><tex-math id="M75">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {P}_i^{GS}\left(\infty \right) $$\end{document}</tex-math><mml:math id="M76" display="inline"><mml:msubsup><mml:mi>P</mml:mi><mml:mi>i</mml:mi><mml:mi mathvariant="italic">GS</mml:mi></mml:msubsup><mml:mfenced close=")" open="("><mml:mo>∞</mml:mo></mml:mfenced></mml:math><inline-graphic xlink:href="12859_2019_3216_Article_IEq18.gif"/></alternatives></inline-formula>, the stable state of <inline-formula id="IEq19"><alternatives><tex-math id="M77">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {P}_i^{TCS}\left(\infty \right) $$\end{document}</tex-math><mml:math id="M78" display="inline"><mml:msubsup><mml:mi>P</mml:mi><mml:mi>i</mml:mi><mml:mi mathvariant="italic">TCS</mml:mi></mml:msubsup><mml:mfenced close=")" open="("><mml:mo>∞</mml:mo></mml:mfenced></mml:math><inline-graphic xlink:href="12859_2019_3216_Article_IEq19.gif"/></alternatives></inline-formula> can be reached by the walker much more quickly. However, considering that there may be nodes that are not in the TCS of <italic>Γ</italic><sub><italic>i</italic></sub> but actually associated with the target node, therefore, in order to avoid omissions, during simulation, we will construct a novel stable walking probability vector <inline-formula id="IEq20"><alternatives><tex-math id="M79">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {P}_i^{ANS}\left(\infty \right) $$\end{document}</tex-math><mml:math id="M80" display="inline"><mml:msubsup><mml:mi>P</mml:mi><mml:mi>i</mml:mi><mml:mi mathvariant="italic">ANS</mml:mi></mml:msubsup><mml:mfenced close=")" open="("><mml:mo>∞</mml:mo></mml:mfenced></mml:math><inline-graphic xlink:href="12859_2019_3216_Article_IEq20.gif"/></alternatives></inline-formula> through combining <inline-formula id="IEq21"><alternatives><tex-math id="M81">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {P}_i^{GS}\left(\infty \right) $$\end{document}</tex-math><mml:math id="M82" display="inline"><mml:msubsup><mml:mi>P</mml:mi><mml:mi>i</mml:mi><mml:mi mathvariant="italic">GS</mml:mi></mml:msubsup><mml:mfenced close=")" open="("><mml:mo>∞</mml:mo></mml:mfenced><mml:mspace width="0.25em"/></mml:math><inline-graphic xlink:href="12859_2019_3216_Article_IEq21.gif"/></alternatives></inline-formula>with <inline-formula id="IEq22"><alternatives><tex-math id="M83">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {P}_i^{TCS}\left(\infty \right) $$\end{document}</tex-math><mml:math id="M84" display="inline"><mml:msubsup><mml:mi>P</mml:mi><mml:mi>i</mml:mi><mml:mi mathvariant="italic">TCS</mml:mi></mml:msubsup><mml:mfenced close=")" open="("><mml:mo>∞</mml:mo></mml:mfenced><mml:mspace width="0.25em"/></mml:math><inline-graphic xlink:href="12859_2019_3216_Article_IEq22.gif"/></alternatives></inline-formula>to predict potential lncRNA-disease associations as follows:
<disp-formula id="Equ21"><label>21</label><alternatives><tex-math id="M85">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {P}_i^{ANS}\left(\infty \right)=\frac{\ {P}_i^{GS}\left(\infty \right)+{P}_i^{TCS}\left(\infty \right)}{2} $$\end{document}</tex-math><mml:math id="M86" display="block"><mml:msubsup><mml:mi>P</mml:mi><mml:mi>i</mml:mi><mml:mi mathvariant="italic">ANS</mml:mi></mml:msubsup><mml:mfenced close=")" open="("><mml:mo>∞</mml:mo></mml:mfenced><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mspace width="0.25em"/><mml:msubsup><mml:mi>P</mml:mi><mml:mi>i</mml:mi><mml:mi mathvariant="italic">GS</mml:mi></mml:msubsup><mml:mfenced close=")" open="("><mml:mo>∞</mml:mo></mml:mfenced><mml:mo>+</mml:mo><mml:msubsup><mml:mi>P</mml:mi><mml:mi>i</mml:mi><mml:mi mathvariant="italic">TCS</mml:mi></mml:msubsup><mml:mfenced close=")" open="("><mml:mo>∞</mml:mo></mml:mfenced></mml:mrow><mml:mn>2</mml:mn></mml:mfrac></mml:math><graphic xlink:href="12859_2019_3216_Article_Equ21.gif" position="anchor"/></alternatives></disp-formula></p>
        </sec>
      </sec>
    </sec>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary information</title>
    <sec id="Sec23">
      <p>
        <supplementary-material content-type="local-data" id="MOESM1">
          <media xlink:href="12859_2019_3216_MOESM1_ESM.txt">
            <caption>
              <p><bold>Additional file 1.</bold> The known lncRNA-disease associations for constructing the known lncRNA-disease network. We list 1695 known lncRNA-disease associations which were collected from LncRNAdisease datasetit is the latest version in the database.</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM2">
          <media xlink:href="12859_2019_3216_MOESM2_ESM.xls">
            <caption>
              <p><bold>Additional file 2.</bold> The known 828 lncRNAs name Included in the 1695 known lncRNA-disease associations which were collected from LncRNAdisease datasetit is the latest version in the database.</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM3">
          <media xlink:href="12859_2019_3216_MOESM3_ESM.xls">
            <caption>
              <p><bold>Additional file 3.</bold> The known 314 diseases name Included in the 1695 known lncRNA-disease associations which were collected from LncRNAdisease datasetit is the latest version in the database.</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM4">
          <media xlink:href="12859_2019_3216_MOESM4_ESM.xls">
            <caption>
              <p><bold>Additional file 4.</bold> The known 98 human cancer,668 lncRNAs and 1103 confirmed associations between them from Lnc2Cancer database.</p>
            </caption>
          </media>
        </supplementary-material>
      </p>
    </sec>
  </sec>
</body>
<back>
  <glossary>
    <title>Abbreviations</title>
    <def-list>
      <def-item>
        <term>10-Fold CV</term>
        <def>
          <p id="Par4">10-fold cross-validation</p>
        </def>
      </def-item>
      <def-item>
        <term>2-Fold CV</term>
        <def>
          <p id="Par5">2-fold cross-validation;</p>
        </def>
      </def-item>
      <def-item>
        <term>5-Fold CV</term>
        <def>
          <p id="Par6">5-fold cross-validation</p>
        </def>
      </def-item>
      <def-item>
        <term>AUC</term>
        <def>
          <p id="Par7">Areas under ROC curve</p>
        </def>
      </def-item>
      <def-item>
        <term>AUPR</term>
        <def>
          <p id="Par8">Area under the precision-recall curve</p>
        </def>
      </def-item>
      <def-item>
        <term>FPR</term>
        <def>
          <p id="Par9">False positive rates</p>
        </def>
      </def-item>
      <def-item>
        <term>GS</term>
        <def>
          <p id="Par10">Global set</p>
        </def>
      </def-item>
      <def-item>
        <term>H19</term>
        <def>
          <p id="Par11">Long non-coding RNA H19</p>
        </def>
      </def-item>
      <def-item>
        <term>lncRNAs</term>
        <def>
          <p id="Par12">Long non-coding RNAs</p>
        </def>
      </def-item>
      <def-item>
        <term>LOOCV</term>
        <def>
          <p id="Par13">Leave-One Out Cross Validation</p>
        </def>
      </def-item>
      <def-item>
        <term>ncRNAs</term>
        <def>
          <p id="Par14">Non-coding RNAs</p>
        </def>
      </def-item>
      <def-item>
        <term>P-R curve</term>
        <def>
          <p id="Par15">Precision-recall curve</p>
        </def>
      </def-item>
      <def-item>
        <term>ROC</term>
        <def>
          <p id="Par16">Receiver-operating characteristics</p>
        </def>
      </def-item>
      <def-item>
        <term>RWR</term>
        <def>
          <p id="Par17">Random walk with restart</p>
        </def>
      </def-item>
      <def-item>
        <term>TCS</term>
        <def>
          <p id="Par18">Target Convergence Set</p>
        </def>
      </def-item>
      <def-item>
        <term>TCSRWRLD</term>
        <def>
          <p id="Par19">A novel computational model based on improved rand walk with restart is proposed to infer potential lncRNA-disease associations</p>
        </def>
      </def-item>
      <def-item>
        <term>TPR</term>
        <def>
          <p id="Par20">True positive rates</p>
        </def>
      </def-item>
      <def-item>
        <term>Xist</term>
        <def>
          <p id="Par21">Long non-coding RNA Xist</p>
        </def>
      </def-item>
    </def-list>
  </glossary>
  <fn-group>
    <fn>
      <p>
        <bold>Publisher’s Note</bold>
      </p>
      <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
    </fn>
  </fn-group>
  <sec>
    <title>Supplementary information</title>
    <p><bold>Supplementary information</bold> accompanies this paper at 10.1186/s12859-019-3216-4.</p>
  </sec>
  <ack>
    <title>Acknowledgements</title>
    <p>The authors thank the anonymous referees for suggestions that helped improve the paper substantially.</p>
  </ack>
  <notes notes-type="author-contribution">
    <title>Author’s contributions</title>
    <p>JCL conceived the study. JCL, XF, LW improved the study based on the original model. XYL, BW and BHZ implemented the algorithms corresponding to the study. LW supervised the study. JCL and LW wrote the manuscript of the study. All authors reviewed and improved the manuscript.</p>
  </notes>
  <notes notes-type="funding-information">
    <title>Funding</title>
    <p>This research was partly sponsored by the National Natural Science Foundation of China (No.61873221,No. 61672447) and the Natural Science Foundation of Hunan Province (No.2018JJ4058, No.2019JJ70010, No.2017JJ5036). Publication costs were funded by the National Natural Science Foundation of China (No.61873221,No.61672447). The funder of manuscript is Lei Wang(L.W.),whose contribution are stated in the section of Author’s Contributions. The funding body has not played any roles in the design of the study and collection,analysis and interpretation of data in writing the manuscript.</p>
  </notes>
  <notes notes-type="data-availability">
    <title>Availability of data and materials</title>
    <p>The datasets generated and/or analysed during the current study are available in the LncRNADisease repository, <ext-link ext-link-type="uri" xlink:href="http://www.cuilab.cn/">http://www.cuilab.cn/</ext-link> lncrnadisease.</p>
  </notes>
  <notes>
    <title>Ethics approval and consent to participate</title>
    <p id="Par71">Not applicable.</p>
  </notes>
  <notes>
    <title>Consent for publication</title>
    <p id="Par72">Not applicable.</p>
  </notes>
  <notes notes-type="COI-statement">
    <title>Competing interests</title>
    <p id="Par73">The authors declare that they have no competing interests.</p>
  </notes>
  <ref-list id="Bib1">
    <title>References</title>
    <ref id="CR1">
      <label>1.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Crick</surname>
            <given-names>FHC</given-names>
          </name>
          <name>
            <surname>Barnett</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Brenner</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Watts-Tobin</surname>
            <given-names>RJ</given-names>
          </name>
        </person-group>
        <article-title>General nature of the genetic code for proteins</article-title>
        <source>Nat</source>
        <year>1961</year>
        <volume>192</volume>
        <issue>4809</issue>
        <fpage>1227</fpage>
        <lpage>1232</lpage>
        <pub-id pub-id-type="doi">10.1038/1921227a0</pub-id>
      </element-citation>
    </ref>
    <ref id="CR2">
      <label>2.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yanofsky</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>Establishing the triplet nature of the genetic code</article-title>
        <source>Cell</source>
        <year>2007</year>
        <volume>128</volume>
        <issue>5</issue>
        <fpage>815</fpage>
        <lpage>818</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cell.2007.02.029</pub-id>
        <?supplied-pmid 17350564?>
        <pub-id pub-id-type="pmid">17350564</pub-id>
      </element-citation>
    </ref>
    <ref id="CR3">
      <label>3.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jean-Michel</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>Fewer genes, more noncoding RNA</article-title>
        <source>Sci</source>
        <year>2005</year>
        <volume>309</volume>
        <issue>5740</issue>
        <fpage>1529</fpage>
        <lpage>1530</lpage>
        <pub-id pub-id-type="doi">10.1126/science.1116800</pub-id>
      </element-citation>
    </ref>
    <ref id="CR4">
      <label>4.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Core</surname>
            <given-names>LJ</given-names>
          </name>
          <name>
            <surname>Waterfall</surname>
            <given-names>JJ</given-names>
          </name>
          <name>
            <surname>Lis</surname>
            <given-names>JT</given-names>
          </name>
        </person-group>
        <article-title>Nascent RNA sequencing reveals widespread pausing and divergent initiation at human promoters</article-title>
        <source>Sci</source>
        <year>2008</year>
        <volume>322</volume>
        <issue>5909</issue>
        <fpage>1845</fpage>
        <lpage>1848</lpage>
        <pub-id pub-id-type="doi">10.1126/science.1162228</pub-id>
      </element-citation>
    </ref>
    <ref id="CR5">
      <label>5.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Paul</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Viktor</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Royce</surname>
            <given-names>TE</given-names>
          </name>
          <name>
            <surname>Rozowsky</surname>
            <given-names>JS</given-names>
          </name>
          <name>
            <surname>Urban</surname>
            <given-names>AE</given-names>
          </name>
          <name>
            <surname>Xiaowei</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Rinn</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Waraporn</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Manoj</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Sherman</surname>
            <given-names>W</given-names>
          </name>
        </person-group>
        <article-title>Global identification of human transcribed sequences with genome tiling arrays</article-title>
        <source>Sci</source>
        <year>2004</year>
        <volume>306</volume>
        <issue>5705</issue>
        <fpage>2242</fpage>
        <lpage>2246</lpage>
        <pub-id pub-id-type="doi">10.1126/science.1103388</pub-id>
      </element-citation>
    </ref>
    <ref id="CR6">
      <label>6.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Piero</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Albin</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Boris</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Shintaro</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Kazuro</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Jasmina</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Semple</surname>
            <given-names>CAM</given-names>
          </name>
          <name>
            <surname>Taylor</surname>
            <given-names>MS</given-names>
          </name>
        </person-group>
        <article-title>Engstr?M PRG, Frith MC: genome-wide analysis of mammalian promoter architecture and evolution</article-title>
        <source>Nat Genet</source>
        <year>2006</year>
        <volume>38</volume>
        <issue>6</issue>
        <fpage>626</fpage>
        <lpage>635</lpage>
        <pub-id pub-id-type="doi">10.1038/ng1789</pub-id>
        <pub-id pub-id-type="pmid">16645617</pub-id>
      </element-citation>
    </ref>
    <ref id="CR7">
      <label>7.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Nina</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Damjan</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>Long non-coding RNA in cancer</article-title>
        <source>Int J Mol Sci</source>
        <year>2013</year>
        <volume>14</volume>
        <issue>3</issue>
        <fpage>4655</fpage>
        <lpage>4669</lpage>
        <pub-id pub-id-type="doi">10.3390/ijms14034655</pub-id>
        <pub-id pub-id-type="pmid">23443164</pub-id>
      </element-citation>
    </ref>
    <ref id="CR8">
      <label>8.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mercer</surname>
            <given-names>TR</given-names>
          </name>
          <name>
            <surname>Dinger</surname>
            <given-names>ME</given-names>
          </name>
          <name>
            <surname>Mattick</surname>
            <given-names>JS</given-names>
          </name>
        </person-group>
        <article-title>Long non-coding RNAs: insights into functions</article-title>
        <source>Nat Rev Genet</source>
        <year>2009</year>
        <volume>10</volume>
        <issue>3</issue>
        <fpage>155</fpage>
        <lpage>159</lpage>
        <pub-id pub-id-type="doi">10.1038/nrg2521</pub-id>
        <pub-id pub-id-type="pmid">19188922</pub-id>
      </element-citation>
    </ref>
    <ref id="CR9">
      <label>9.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mitchell</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Pamela</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Ingolia</surname>
            <given-names>NT</given-names>
          </name>
          <name>
            <surname>Weissman</surname>
            <given-names>JS</given-names>
          </name>
          <name>
            <surname>Lander</surname>
            <given-names>ES</given-names>
          </name>
        </person-group>
        <article-title>Ribosome profiling provides evidence that large noncoding RNAs do not encode proteins</article-title>
        <source>Cell</source>
        <year>2013</year>
        <volume>154</volume>
        <issue>1</issue>
        <fpage>240</fpage>
        <lpage>251</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cell.2013.06.009</pub-id>
        <pub-id pub-id-type="pmid">23810193</pub-id>
      </element-citation>
    </ref>
    <ref id="CR10">
      <label>10.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Borsani</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Tonlorenzi</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Simmler</surname>
            <given-names>MC</given-names>
          </name>
          <name>
            <surname>Dandolo</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Arnaud</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Capra</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Grompe</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Pizzuti</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Muzny</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Lawrence</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>Characterization of a murine gene expressed from the inactive X chromosome</article-title>
        <source>Nat</source>
        <year>1991</year>
        <volume>351</volume>
        <issue>6324</issue>
        <fpage>325</fpage>
        <lpage>329</lpage>
        <pub-id pub-id-type="doi">10.1038/351325a0</pub-id>
      </element-citation>
    </ref>
    <ref id="CR11">
      <label>11.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Brockdorff</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Ashworth</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Kay</surname>
            <given-names>GF</given-names>
          </name>
          <name>
            <surname>Mccabe</surname>
            <given-names>VM</given-names>
          </name>
          <name>
            <surname>Norris</surname>
            <given-names>DP</given-names>
          </name>
          <name>
            <surname>Cooper</surname>
            <given-names>PJ</given-names>
          </name>
          <name>
            <surname>Swift</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Rastan</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>The product of the mouse Xist gene is a 15 kb inactive X-specific transcript containing no conserved ORF and located in the nucleus</article-title>
        <source>Cell</source>
        <year>1992</year>
        <volume>71</volume>
        <issue>3</issue>
        <fpage>515</fpage>
        <lpage>526</lpage>
        <pub-id pub-id-type="doi">10.1016/0092-8674(92)90519-I</pub-id>
        <?supplied-pmid 1423610?>
        <pub-id pub-id-type="pmid">1423610</pub-id>
      </element-citation>
    </ref>
    <ref id="CR12">
      <label>12.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mitchell</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Manuel</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Levin</surname>
            <given-names>JZ</given-names>
          </name>
          <name>
            <surname>Julie</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>James</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Xian</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Koziol</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>Andreas</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Chad</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>Ab initio reconstruction of cell type-specific transcriptomes in mouse reveals the conserved multi-exonic structure of lincRNAs</article-title>
        <source>Nat Biotechnol</source>
        <year>2010</year>
        <volume>28</volume>
        <issue>5</issue>
        <fpage>503</fpage>
        <lpage>510</lpage>
        <pub-id pub-id-type="doi">10.1038/nbt.1633</pub-id>
        <pub-id pub-id-type="pmid">20436462</pub-id>
      </element-citation>
    </ref>
    <ref id="CR13">
      <label>13.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Guttman</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Amit</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Garber</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>French</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>MF</given-names>
          </name>
          <name>
            <surname>Feldser</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Huarte</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Zuk</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Carey</surname>
            <given-names>BW</given-names>
          </name>
          <name>
            <surname>Cassady</surname>
            <given-names>JP</given-names>
          </name>
        </person-group>
        <article-title>Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals</article-title>
        <source>Nature</source>
        <year>2009</year>
        <volume>458</volume>
        <issue>7235</issue>
        <fpage>223</fpage>
        <pub-id pub-id-type="doi">10.1038/nature07672</pub-id>
        <?supplied-pmid 19182780?>
        <pub-id pub-id-type="pmid">19182780</pub-id>
      </element-citation>
    </ref>
    <ref id="CR14">
      <label>14.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ponting</surname>
            <given-names>CP</given-names>
          </name>
          <name>
            <surname>Oliver</surname>
            <given-names>PL</given-names>
          </name>
          <name>
            <surname>Reik</surname>
            <given-names>W</given-names>
          </name>
        </person-group>
        <article-title>Evolution and functions of long noncoding RNAs</article-title>
        <source>Cell</source>
        <year>2009</year>
        <volume>136</volume>
        <issue>4</issue>
        <fpage>629</fpage>
        <lpage>641</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cell.2009.02.006</pub-id>
        <?supplied-pmid 19239885?>
        <pub-id pub-id-type="pmid">19239885</pub-id>
      </element-citation>
    </ref>
    <ref id="CR15">
      <label>15.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wilusz</surname>
            <given-names>JE</given-names>
          </name>
          <name>
            <surname>Hongjae</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Spector</surname>
            <given-names>DL</given-names>
          </name>
        </person-group>
        <article-title>Long noncoding RNAs: functional surprises from the RNA world</article-title>
        <source>Genes Dev</source>
        <year>2009</year>
        <volume>23</volume>
        <issue>13</issue>
        <fpage>1494</fpage>
        <lpage>1504</lpage>
        <pub-id pub-id-type="doi">10.1101/gad.1800909</pub-id>
        <?supplied-pmid 3152381?>
        <pub-id pub-id-type="pmid">19571179</pub-id>
      </element-citation>
    </ref>
    <ref id="CR16">
      <label>16.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gupta</surname>
            <given-names>RA</given-names>
          </name>
          <name>
            <surname>Nilay</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>KC</given-names>
          </name>
          <name>
            <surname>Jeewon</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Horlings</surname>
            <given-names>HM</given-names>
          </name>
          <name>
            <surname>Wong</surname>
            <given-names>DJ</given-names>
          </name>
          <name>
            <surname>Miao-Chih</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Tiffany</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Pedram</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Rinn</surname>
            <given-names>JL</given-names>
          </name>
        </person-group>
        <article-title>Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis</article-title>
        <source>Nature</source>
        <year>2010</year>
        <volume>464</volume>
        <issue>7291</issue>
        <fpage>1071</fpage>
        <lpage>1076</lpage>
        <pub-id pub-id-type="doi">10.1038/nature08975</pub-id>
        <?supplied-pmid 20393566?>
        <pub-id pub-id-type="pmid">20393566</pub-id>
      </element-citation>
    </ref>
    <ref id="CR17">
      <label>17.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pibouin</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Villaudy</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Ferbus</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Muleris</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Prospéri</surname>
            <given-names>MT</given-names>
          </name>
          <name>
            <surname>Remvikos</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Goubin</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>Cloning of the mRNA of overexpression in colon carcinoma-1 : a sequence overexpressed in a subset of colon carcinomas</article-title>
        <source>Cancer Genet Cytogenet</source>
        <year>2002</year>
        <volume>133</volume>
        <issue>1</issue>
        <fpage>55</fpage>
        <lpage>60</lpage>
        <pub-id pub-id-type="doi">10.1016/S0165-4608(01)00634-3</pub-id>
        <?supplied-pmid 11890990?>
        <pub-id pub-id-type="pmid">11890990</pub-id>
      </element-citation>
    </ref>
    <ref id="CR18">
      <label>18.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ji</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Diederichs</surname>
            <given-names>SW</given-names>
          </name>
          <name>
            <surname>Boing</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Metzger</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Schneider</surname>
            <given-names>PM</given-names>
          </name>
          <name>
            <surname>Tidow</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Brandt</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Buerger</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Bulk</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Thomas</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer</article-title>
        <source>Oncogene</source>
        <year>2003</year>
        <volume>22</volume>
        <issue>39</issue>
        <fpage>8031</fpage>
        <pub-id pub-id-type="doi">10.1038/sj.onc.1206928</pub-id>
        <?supplied-pmid 12970751?>
        <pub-id pub-id-type="pmid">12970751</pub-id>
      </element-citation>
    </ref>
    <ref id="CR19">
      <label>19.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Spizzo</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Almeida</surname>
            <given-names>MI</given-names>
          </name>
          <name>
            <surname>Colombatti</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Calin</surname>
            <given-names>GA</given-names>
          </name>
        </person-group>
        <article-title>Long non-coding RNAs and cancer: a new frontier of translational research?</article-title>
        <source>Oncogene</source>
        <year>2012</year>
        <volume>31</volume>
        <issue>43</issue>
        <fpage>4577</fpage>
        <lpage>4587</lpage>
        <pub-id pub-id-type="doi">10.1038/onc.2011.621</pub-id>
        <?supplied-pmid 22266873?>
        <pub-id pub-id-type="pmid">22266873</pub-id>
      </element-citation>
    </ref>
    <ref id="CR20">
      <label>20.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Qiu</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Yan</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Cui</surname>
            <given-names>Q</given-names>
          </name>
        </person-group>
        <article-title>LncRNADisease: a database for long-non-coding RNA-associated diseases</article-title>
        <source>Nucleic Acids Res</source>
        <year>2012</year>
        <volume>41</volume>
        <issue>D1</issue>
        <fpage>D983</fpage>
        <lpage>D986</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gks1099</pub-id>
        <?supplied-pmid 3531173?>
        <pub-id pub-id-type="pmid">23175614</pub-id>
      </element-citation>
    </ref>
    <ref id="CR21">
      <label>21.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Quek</surname>
            <given-names>XC</given-names>
          </name>
          <name>
            <surname>Thomson</surname>
            <given-names>DW</given-names>
          </name>
          <name>
            <surname>Maag</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Bartonicek</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Signal</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Clark</surname>
            <given-names>MB</given-names>
          </name>
          <name>
            <surname>Gloss</surname>
            <given-names>BS</given-names>
          </name>
        </person-group>
        <article-title>Dinger ME.lncRNAdb v2.0: expanding the reference database for functional long noncoding RNAs</article-title>
        <source>Nucleic Acids Res</source>
        <year>2015</year>
        <volume>43</volume>
        <issue>Database issue</issue>
        <fpage>D168</fpage>
        <lpage>D173</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gku988</pub-id>
        <?supplied-pmid 25332394?>
        <pub-id pub-id-type="pmid">25332394</pub-id>
      </element-citation>
    </ref>
    <ref id="CR22">
      <label>22.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bu</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Xie</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Skogerbø</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Miao</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Xiao</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Liao</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Luo</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>NONCODE v3. 0: integrative annotation of long noncoding RNAs</article-title>
        <source>Nucleic Acids Res</source>
        <year>2011</year>
        <volume>40</volume>
        <issue>D1</issue>
        <fpage>D210</fpage>
        <lpage>D215</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkr1175</pub-id>
        <?supplied-pmid 22135294?>
        <pub-id pub-id-type="pmid">22135294</pub-id>
      </element-citation>
    </ref>
    <ref id="CR23">
      <label>23.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ning</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Zhi</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Gao</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Guo</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Yue</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>Lnc2Cancer: a manually curated database of experimentally supported lncRNAs associated with various human cancers</article-title>
        <source>Nucleic Acids Res</source>
        <year>2015</year>
        <volume>44</volume>
        <issue>D1</issue>
        <fpage>D980</fpage>
        <lpage>D985</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkv1094</pub-id>
        <?supplied-pmid 26481356?>
        <pub-id pub-id-type="pmid">26481356</pub-id>
      </element-citation>
    </ref>
    <ref id="CR24">
      <label>24.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ideker</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Sharan</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>Protein networks in disease</article-title>
        <source>Genome Res</source>
        <year>2008</year>
        <volume>18</volume>
        <issue>4</issue>
        <fpage>644</fpage>
        <lpage>652</lpage>
        <pub-id pub-id-type="doi">10.1101/gr.071852.107</pub-id>
        <?supplied-pmid 18381899?>
        <pub-id pub-id-type="pmid">18381899</pub-id>
      </element-citation>
    </ref>
    <ref id="CR25">
      <label>25.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ming</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Qipeng</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Min</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Jing</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Yanhong</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Wei</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Qinghua</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>An analysis of human microRNA and disease associations</article-title>
        <source>PLoS One</source>
        <year>2008</year>
        <volume>3</volume>
        <issue>10</issue>
        <fpage>e3420</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0003420</pub-id>
        <pub-id pub-id-type="pmid">18923704</pub-id>
      </element-citation>
    </ref>
    <ref id="CR26">
      <label>26.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Xing</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Gui-Ying</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>Novel human lncRNA-disease association inference based on lncRNA expression profiles</article-title>
        <source>Bioinformatics</source>
        <year>2013</year>
        <volume>29</volume>
        <issue>20</issue>
        <fpage>2617</fpage>
        <lpage>2624</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btt426</pub-id>
        <pub-id pub-id-type="pmid">24002109</pub-id>
      </element-citation>
    </ref>
    <ref id="CR27">
      <label>27.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ping</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Kuang</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Ye</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Iqbal</surname>
            <given-names>MFB</given-names>
          </name>
          <name>
            <surname>Pei</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>A novel method for lncRNA-disease association prediction based on an lncRNA-disease association network</article-title>
        <source>IEEE/ACM Trans Comput Biol Bioinform</source>
        <year>2018</year>
        <volume>16</volume>
        <issue>2</issue>
        <fpage>688</fpage>
        <lpage>693</lpage>
        <pub-id pub-id-type="doi">10.1109/TCBB.2018.2827373</pub-id>
        <?supplied-pmid 29993639?>
        <pub-id pub-id-type="pmid">29993639</pub-id>
      </element-citation>
    </ref>
    <ref id="CR28">
      <label>28.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhao</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Kuang</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Ping</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Xuan</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Pei</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>Z</given-names>
          </name>
        </person-group>
        <article-title>Prediction of microRNA-disease associations based on distance correlation set</article-title>
        <source>BMC Bioinformatics</source>
        <year>2018</year>
        <volume>19</volume>
        <issue>1</issue>
        <fpage>141</fpage>
        <pub-id pub-id-type="doi">10.1186/s12859-018-2146-x</pub-id>
        <?supplied-pmid 29665774?>
        <pub-id pub-id-type="pmid">29665774</pub-id>
      </element-citation>
    </ref>
    <ref id="CR29">
      <label>29.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>X</given-names>
          </name>
        </person-group>
        <article-title>KATZLDA: KATZ measure for the lncRNA-disease association prediction</article-title>
        <source>Sci Rep</source>
        <year>2014</year>
        <volume>5</volume>
        <issue>1</issue>
        <fpage>16840</fpage>
        <pub-id pub-id-type="doi">10.1038/srep16840</pub-id>
      </element-citation>
    </ref>
    <ref id="CR30">
      <label>30.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Katz</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>A new status index derived from sociometric analysis</article-title>
        <source>Psychometrika</source>
        <year>1953</year>
        <volume>18</volume>
        <issue>1</issue>
        <fpage>39</fpage>
        <lpage>43</lpage>
        <pub-id pub-id-type="doi">10.1007/BF02289026</pub-id>
      </element-citation>
    </ref>
    <ref id="CR31">
      <label>31.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Yan</surname>
            <given-names>CC</given-names>
          </name>
          <name>
            <surname>Luo</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Ji</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Dai</surname>
            <given-names>Q</given-names>
          </name>
        </person-group>
        <article-title>Constructing lncRNA functional similarity network based on lncRNA-disease associations and disease semantic similarity</article-title>
        <source>Sci Rep</source>
        <year>2015</year>
        <volume>5</volume>
        <fpage>11338</fpage>
        <pub-id pub-id-type="doi">10.1038/srep11338</pub-id>
        <?supplied-pmid 4462156?>
        <pub-id pub-id-type="pmid">26061969</pub-id>
      </element-citation>
    </ref>
    <ref id="CR32">
      <label>32.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>MX</given-names>
          </name>
          <name>
            <surname>Yan</surname>
            <given-names>GY</given-names>
          </name>
        </person-group>
        <article-title>RWRMDA: predicting novel human microRNA-disease associations</article-title>
        <source>Mol BioSyst</source>
        <year>2012</year>
        <volume>8</volume>
        <issue>10</issue>
        <fpage>2792</fpage>
        <lpage>2798</lpage>
        <pub-id pub-id-type="doi">10.1039/c2mb25180a</pub-id>
        <pub-id pub-id-type="pmid">22875290</pub-id>
      </element-citation>
    </ref>
    <ref id="CR33">
      <label>33.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>X</given-names>
          </name>
        </person-group>
        <article-title>miREFRWR: a novel disease-related microRNA-environmental factor interactions prediction method</article-title>
        <source>Mol BioSyst</source>
        <year>2016</year>
        <volume>12</volume>
        <issue>2</issue>
        <fpage>624</fpage>
        <lpage>633</lpage>
        <pub-id pub-id-type="doi">10.1039/C5MB00697J</pub-id>
        <?supplied-pmid 26689259?>
        <pub-id pub-id-type="pmid">26689259</pub-id>
      </element-citation>
    </ref>
    <ref id="CR34">
      <label>34.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>M-X</given-names>
          </name>
          <name>
            <surname>Yan</surname>
            <given-names>G-Y</given-names>
          </name>
        </person-group>
        <article-title>Drug–target interaction prediction by random walk on the heterogeneous network</article-title>
        <source>Mol BioSyst</source>
        <year>2012</year>
        <volume>8</volume>
        <issue>7</issue>
        <fpage>1970</fpage>
        <lpage>1978</lpage>
        <pub-id pub-id-type="doi">10.1039/c2mb00002d</pub-id>
        <?supplied-pmid 22538619?>
        <pub-id pub-id-type="pmid">22538619</pub-id>
      </element-citation>
    </ref>
    <ref id="CR35">
      <label>35.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jie</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Hongbo</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Zhenzhen</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Changjian</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Letian</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Weiwei</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Dapeng</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Shulin</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Meng</surname>
            <given-names>Z</given-names>
          </name>
        </person-group>
        <article-title>Inferring novel lncRNA-disease associations based on a random walk model of a lncRNA functional similarity network</article-title>
        <source>Mol BioSyst</source>
        <year>2014</year>
        <volume>10</volume>
        <issue>8</issue>
        <fpage>2074</fpage>
        <lpage>2081</lpage>
        <pub-id pub-id-type="doi">10.1039/C3MB70608G</pub-id>
        <pub-id pub-id-type="pmid">24850297</pub-id>
      </element-citation>
    </ref>
    <ref id="CR36">
      <label>36.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>You</surname>
            <given-names>ZH</given-names>
          </name>
          <name>
            <surname>Yan</surname>
            <given-names>GY</given-names>
          </name>
          <name>
            <surname>Gong</surname>
            <given-names>DW</given-names>
          </name>
        </person-group>
        <article-title>IRWRLDA: improved random walk with restart for lncRNA-disease association prediction</article-title>
        <source>Oncotarget</source>
        <year>2016</year>
        <volume>7</volume>
        <issue>36</issue>
        <fpage>57919</fpage>
        <lpage>57931</lpage>
        <?supplied-pmid 27517318?>
        <pub-id pub-id-type="pmid">27517318</pub-id>
      </element-citation>
    </ref>
    <ref id="CR37">
      <label>37.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fan</surname>
            <given-names>XN</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>SW</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>SY</given-names>
          </name>
          <name>
            <surname>Zhu</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Lu</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Prediction of lncRNA-disease associations by integrating diverse heterogeneous information sources with RWR algorithm and positive pointwise mutual information</article-title>
        <source>BMC Bioinformatics</source>
        <year>2019</year>
        <volume>20</volume>
        <issue>1</issue>
        <fpage>87</fpage>
        <pub-id pub-id-type="doi">10.1186/s12859-019-2675-y</pub-id>
        <?supplied-pmid 30782113?>
        <pub-id pub-id-type="pmid">30782113</pub-id>
      </element-citation>
    </ref>
    <ref id="CR38">
      <label>38.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Xuan</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Feng</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>A probabilistic matrix factorization method for identifying lncRNA-disease associations</article-title>
        <source>Genes</source>
        <year>2019</year>
        <volume>10</volume>
        <issue>2</issue>
        <fpage>126</fpage>
        <pub-id pub-id-type="doi">10.3390/genes10020126</pub-id>
        <?supplied-pmid 6410097?>
        <pub-id pub-id-type="pmid">6410097</pub-id>
      </element-citation>
    </ref>
    <ref id="CR39">
      <label>39.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>van Laarhoven</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Nabuurs</surname>
            <given-names>SB</given-names>
          </name>
          <name>
            <surname>Marchiori</surname>
            <given-names>E</given-names>
          </name>
        </person-group>
        <article-title>Gaussian interaction profile kernels for predicting drug–target interaction</article-title>
        <source>Bioinformatics</source>
        <year>2011</year>
        <volume>27</volume>
        <issue>21</issue>
        <fpage>3036</fpage>
        <lpage>3043</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btr500</pub-id>
        <?supplied-pmid 21893517?>
        <pub-id pub-id-type="pmid">21893517</pub-id>
      </element-citation>
    </ref>
    <ref id="CR40">
      <label>40.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Spiess</surname>
            <given-names>PE</given-names>
          </name>
          <name>
            <surname>Dhillon</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Baumgarten</surname>
            <given-names>AS</given-names>
          </name>
          <name>
            <surname>Johnstone</surname>
            <given-names>PA</given-names>
          </name>
          <name>
            <surname>Giuliano</surname>
            <given-names>AR</given-names>
          </name>
        </person-group>
        <article-title>Pathophysiological basis of human papillomavirus in penile cancer: key to prevention and delivery of more effective therapies</article-title>
        <source>CA Cancer J Clin</source>
        <year>2016</year>
        <volume>66</volume>
        <issue>6</issue>
        <fpage>481</fpage>
        <lpage>495</lpage>
        <pub-id pub-id-type="doi">10.3322/caac.21354</pub-id>
        <?supplied-pmid 27314890?>
        <pub-id pub-id-type="pmid">27314890</pub-id>
      </element-citation>
    </ref>
    <ref id="CR41">
      <label>41.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tony</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Monika</surname>
            <given-names>HM</given-names>
          </name>
          <name>
            <surname>Moritz</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Jeff</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Youngsoo</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Alexey</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Gayatri</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Marion</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Matthias</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells</article-title>
        <source>Cancer Res</source>
        <year>2013</year>
        <volume>73</volume>
        <issue>3</issue>
        <fpage>1180</fpage>
        <lpage>1189</lpage>
        <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-12-2850</pub-id>
        <pub-id pub-id-type="pmid">23243023</pub-id>
      </element-citation>
    </ref>
    <ref id="CR42">
      <label>42.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>White</surname>
            <given-names>NM</given-names>
          </name>
          <name>
            <surname>Cabanski</surname>
            <given-names>CR</given-names>
          </name>
          <name>
            <surname>Silva-Fisher</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Dang</surname>
            <given-names>HX</given-names>
          </name>
          <name>
            <surname>Govindan</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Maher</surname>
            <given-names>CA</given-names>
          </name>
        </person-group>
        <article-title>Transcriptome sequencing reveals altered long intergenic non-coding RNAs in lung cancer</article-title>
        <source>Genome Biol</source>
        <year>2014</year>
        <volume>15</volume>
        <issue>8</issue>
        <fpage>429</fpage>
        <pub-id pub-id-type="doi">10.1186/s13059-014-0429-8</pub-id>
        <?supplied-pmid 25116943?>
        <pub-id pub-id-type="pmid">25116943</pub-id>
      </element-citation>
    </ref>
    <ref id="CR43">
      <label>43.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Omer</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Singh</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Yadav</surname>
            <given-names>NK</given-names>
          </name>
        </person-group>
        <article-title>Singh RK: microRNAs: role in leukemia and their computational perspective</article-title>
        <source>Wiley Interdiscip Rev: RNA</source>
        <year>2015</year>
        <volume>6</volume>
        <issue>1</issue>
        <fpage>65</fpage>
        <lpage>78</lpage>
        <pub-id pub-id-type="doi">10.1002/wrna.1256</pub-id>
        <?supplied-pmid 25132152?>
        <pub-id pub-id-type="pmid">25132152</pub-id>
      </element-citation>
    </ref>
    <ref id="CR44">
      <label>44.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Lu</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Song</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Cui</surname>
            <given-names>Q</given-names>
          </name>
        </person-group>
        <article-title>Inferring the human microRNA functional similarity and functional network based on microRNA-associated diseases</article-title>
        <source>Bioinform</source>
        <year>2010</year>
        <volume>26</volume>
        <issue>13</issue>
        <fpage>1644</fpage>
        <lpage>1650</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btq241</pub-id>
      </element-citation>
    </ref>
    <ref id="CR45">
      <label>45.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>X</given-names>
          </name>
        </person-group>
        <article-title>Predicting lncRNA-disease associations and constructing lncRNA functional similarity network based on the information of miRNA</article-title>
        <source>Sci Rep</source>
        <year>2015</year>
        <volume>5</volume>
        <fpage>13186</fpage>
        <pub-id pub-id-type="doi">10.1038/srep13186</pub-id>
        <?supplied-pmid 26278472?>
        <pub-id pub-id-type="pmid">26278472</pub-id>
      </element-citation>
    </ref>
    <ref id="CR46">
      <label>46.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Vanunu</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Magger</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Ruppin</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Shlomi</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Sharan</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>Associating genes and protein complexes with disease via network propagation</article-title>
        <source>PLoS Comput Biol</source>
        <year>2010</year>
        <volume>6</volume>
        <issue>1</issue>
        <fpage>e1000641</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pcbi.1000641</pub-id>
        <?supplied-pmid 20090828?>
        <pub-id pub-id-type="pmid">20090828</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
